Modulation of BMP signaling during Dorsal-Ventral patterning in Drosophila melanogaster by Brakken-Thal, Christina
Modulation of BMP Signaling During
Dorsal-Ventral Patterning in Drosophila
melanogaster
A DISSERTATION
SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL
OF THE UNIVERSITY OF MINNESOTA
BY
Christina Brakken-Thal
IN PARTIAL FULFILLMENT OF THE REQUIREMENTS
FOR THE DEGREE OF
Doctor of Philosophy
Hans Othmer and Michael O’Connor
February, 2014
c© Christina Brakken-Thal 2014
ALL RIGHTS RESERVED
Acknowledgements
I am very grateful to my advisers Hans Othmer and Michael O’Connor for let-
ting me work on this thesis over the past several years. I appreciate all of their
helpful conversations, feedback, support, and patience as I have gone through my
graduate training. I want to thank the past and present members of the Oth-
mer Group and O’Connor Laboratory for their comments and support while I
have worked on these projects. I would like to thank the members of the Devel-
opmental Biology Center and the Mathematical Biology Group for their helpful
comments throughout my training. Dr. Aidan Peterson has been extremely help-
ful in troubleshooting and advising my biology projects. I would also like to thank
him for reading my thesis and his helpful and insightful comments. Mary Jane
O’Connor has been very helpful in troubleshooting the sequencing of nejire in
Chapter 2. Chapter 3 of this thesis was completed in close collaboration with Dr.
Likun Zheng. We developed the models and ran the simulations together for this
i
project.
I am very greatful to several funding sources that supported my throughout
my training. I would like to thank the Biotechnology Training Grant for the first
2 years of my funding. I would like to thank the Warwick Fellowship through
the Graduate School for the third year of my funding. I would like to thank the
Developmental Biology Training Grant for my fourth year of funding. I would
like to thank the Musculoskeletal Training Grant for my fifth year of funding. It
has been a pleasure to get to be a part of these training programs and they have
enriched my graduate school experience immensely.
I would like to thank my family for their love and support in completing this
thesis. I would like to thank my parents Steven Thal and Peggy Brakken Thal
for their support, trust, and encouragement. I would like to thank my husband,
Jeff Thaler, for all his help throughout my PhD. I want to thank him for letting
me discuss my projects, reading my drafts of the thesis, and his support and
encouragement throughout my training. I would like to thank Natalie Thaler and
Peggy Brakken Thal for helping to take care of my son over the last few months
in order to give me more time to complete my thesis. Without all of your help
and support this thesis would not have been possible.
ii
Dedication
This thesis is dedicated to my family. To my parents Steven Thal and Peggy
Brakken Thal for their love and support through my many years of schooling. To
my brother Sean Brakken-Thal for his love and encouragement. To my husband
Jeff Thaler whose love and support throughout my entire thesis would not have
made this possible.
iii
Abstract
Bone Morphogenic Protein (BMP) signaling is a conserved pathway used for
development and homeostasis. In the model system Drosophila melanogaster pat-
terning of the dorsal surface is controlled by Decapentapolegic (DPP), a BMP
protein that robustly stimulates the BMP signaling pathway in a narrow domain
of cells on the dorsal surface of the embryo. The levels of Dpp are estimated to
be between 10-100 molecules / nucleus, which would predict a significant level of
noise in Dpp signaling. However this is not observed, so there must be mechanisms
that dampen noise in signaling pathways. I used molecular biology, genetics, and
mathematical modeling to identify possible mechanisms for feedback control of
BMP signaling and to elucidate mechanisms to dampen stochastic fluctuations in
signaling molecules. I have identified a new novel allele of nejire with a stop codon
in the 12th exon. This mutation truncates part of the glutamine rich domain at
the end of the protein. This new allele has a highly variable phenotype with all
embryos showing varying degrees of loss of Dpp signaling in the pre-cephalic fur-
row embryos, and half showing recovery just before and during gastrulation. I also
studied the phenotype of Crossveinless-2 (Cv-2) during dorsal surface patterning.
iv
I found that cv-2 is a Dpp response gene that is a negative inhibitor of Dpp signal-
ing during dorsal surface patterning. Cv-2 null embryos have a 20% wider area of
Dpp signaling on the dorsal surface, and this change leads to a larger amnioserosa
later in development. Interestingly loss of Cv-2 leads to a slight increase in noise
in the width of pMad, the intracellular signaling of Dpp receptor activation. I
followed up on this finding with a 3D stochastic model of Dpp for a single nuclear
compartment which suggests that competition for BMP from the receptor could
increase noise in signaling. In addition, the stochastic model suggests that endo-
cytosis of Dpp bound receptors and nuclear accumulation of transcription factors
may be mechanisms to decrease noise and increase robustness of Dpp signaling.
v
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Chapter 1
Introduction
1.1 Introduction
Cells transmit information from the extracellular environment into the intracel-
lular environment through signaling pathways to change cell behavior. The basic
mechanism involves ligands binding to receptors on the cellular membrane which
then causes a change in the intracellular environment. Aberrant signaling has
been implicated in many different human diseases ranging from developmental
defects to cancer [1, 2, 3]. Since signaling pathways are ubiquitously used by most
cell types, in order to develop targeted therapies it is important to understand
their regulation and how they are modulated in different settings. In this thesis
1
2I report on studies involving Bone Morphogenic Protein (BMP) signaling to un-
derstand how it is able to robustly pattern the dorsal surface of the Drosophila
embryo. By studying cases of aberrant patterning we can learn how this signaling
pathway is modulated. In particular, I will focus on studying feedback control and
robustness of BMP signaling using molecular biology and mathematical model-
ing. I will quantitatively analyze BMP signaling in early Drosophila development
to better understand its regulation and determine how noise influences Dorsal /
Ventral (D/V) axis patterning.
The BMP ligands are members of the transforming growth factor-β (TGF-β)
superfamily and they are critical for growth, differentiation, pattern formation,
and adult homeostasis [4]. Even though there are differences across species with
respect to downstream target genes that are regulated by TGF-β signaling in spe-
cific tissues, the general mechanisms of feedback and extracellular regulation are
conserved. In vertebrate systems, the greater complexity in the number of ligands,
receptors and downstream signaling components makes the study of BMP signal-
ing more difficult due to redundancy. For example, BMP signaling is required for
craniofacial patterning [5, 6]. However the contributions of signals from individual
ligands to overall pattern can be difficult to determine due to redundancy. Thus,
the mechanisms for how BMP signaling controls craniofacial patterning have re-
mained elusive. In Drosophila the complexity in the numbers of the BMP signaling
3components is much less than in vertebrates enabling a more direct assessment of
how each component contributes to overall signaling network.
1.2 Drosophila as a Model System
Drosophila, commonly known as the fruit fly, is an ideal model system to better
understand basic mechanisms that control signaling pathways. Lower organisms
are easier to study due to their greater simplicity. However, the fundamental prin-
ciples of how different biological processes function is often similar between lower
organisms, such as Drosophila, and higher organisms, such as humans [7]. It has
been estimated that approximately 75% of human disorders with a known genetic
basis have genes with sequence similarities in Drosophila [7]. Thus, Drosophila
can be used as a model system to study how these genes function in order to
develop therapies for treatment or cure of the underlying genetic conditions.
Drosophila has been a major model system for genetics research for over a cen-
tury [8]. The initial theory that inheritance involved transmission of chromosomes
that contained genes coding for different traits was discovered using Drosophila as
a model [8]. Drosophila was also one of the first organisms used in genome wide
mutagenesis screens to look for new phenotypes affecting all aspects of develop-
ment. Based on the rich history of genetics research in Drosophila, it was one of
4the first model organisms to have its genome fully sequenced and annotated in
2000 [9, 10]. The Drosophila genome is 180 Megabases in size and contains at
least 13,739 genes, whereas the human genome is approximately 3.08 Gigabases
and contains about 20,000 genes [11]. The function of novel genes are often first
identified in Drosophila facilitating the understanding of the roles of homologous
genes in vertebrate systems [12].
For research in in the field of developmental biology, Drosophila is advan-
tageous due to its simple growth requirements enabling the production of large
numbers of animals at all stages of development. In addition, the breadth of
available molecular biology and genetic techniques is unmatched by any other or-
ganism. The lifecycle of Drosophila is fairly rapid at approximately two weeks,
making it easy to collect large amounts of data in relatively short time frame
compared to vertebrate model systems. Mutagenesis screens are also easy to im-
plement facilitating the identification of many interesting mutations. Many of
these mutations result in lethality when homozygous but these mutations can be
maintained in a self perpetuating stock through the use of balancer chromosome.
[13]. The balancer chromosomes have multiple inversions to prevent recombina-
tion between chromosomes and dominant mutations that allows the investigator
to trace chromosomal inheritance. Another important tool is the Gal4/UAS sys-
tem that allows for tissue specific expression or knockdown of genes [14, 15].
5P-element transposons can also be used for gene disruption experiments, map-
ping genetic mutations, and for making transgenic animals that contain new gene
configurations[16]. The wide breadth of these tools makes Drosophila an ideal
system for studying control of signaling networks.
The early development of the Drosophila embryo is unusual compared to those
of other model systems. Instead of rapid cell division with complete cytokinesis,
the first 13 early divisions in Drosophila embryos involve nuclear fission within a
large common cytoplasm leading to the formation of a syncytial embryo consist-
ing of about 6000 surface nuclei and 20 or so central nuclei. Initially, the nuclei
are in the center of the embryo, and at nuclear division nine the nuclei migrate
out to the periphery of the embryo, forming a monolayer underneath the plasma
membrane (Figure 1.1). Cellularization of individual surface nuclei commences
during the fourteenth division cycle at about 2 1/2-3 hours of development. Most
of the studies described in this thesis involve characterization of signaling output
in embryos that are between nuclear cycle 9 and 14. A general subdivision of
domains begins around the time of nuclear division nine. However the positional
information along both axes is further refined between nuclear divisions nine to
fourteen. Exterior to the plasma membrane is the perivitelline (PV) space. Pro-
teins are secreted into the PV space where they can diffuse and interact to send
signals back to the cytoplasm and nuclei for patterning tissue boundaries along
6both the Anterior / Posterior (A/P) and D/V axes.
Dorsal 
PV Space 
Ventral 
v 
Plasma 
Membrane 
Figure 1.1: Cross-section of the Early Drosophila Embryo - During early embryo-
genesis nuclei are in a syncytium. At nuclear division nine, the nuclei migrate to
the plasma membrane and form a monolayer under the plasma membrane. Above
the plasma membrane is the PV space. Signaling molecules can be secreted from
the cytoplasm into the PV space where they can diffuse, bind receptors and signal
back to the nuclei.
1.3 BMP Signaling
1.3.1 BMP Signaling Pathway
During D/V patterning in the Drosophila embryo, BMP signals relay positional
information to the nucleus based on the concentration of BMP ligand in the PV
space. The strength of the signal controls the transcriptional output of target
genes. The information flow can be separated into three major phases; first is
7the formation of the active signaling complex in the PV space, the second is
transducing a signal across the plasma membrane into the cytoplasm, and third is
the passing of the signal into the nucleus such that various activator and repressor
transcriptional complexes are assembled onto DNA (Figure 1.2).
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Figure 1.2: Model of the BMP Signaling Pathway - A dimer of BMP (orange and
yellow) ligands is transported within the PV space by Sog (brown) and Tsg (light
green) covering up BMP binding domains. At the dorsal midline Tld (black)
cleaves Sog to release BMP to bind to the type I receptors (dark green) or Cv-2
(pink). The type I receptors recruit a dimer of type II receptors (dark purple)
to form an active signaling complex. This leads the constitutively active type
II receptor to phosphorylate (P) the type I receptor. Then the type I receptor
phosphorylates Mad (dark blue) to pMad. Two pMad molecules combine with a
co-smad, Medea, (light purple) to form an active transcription factor, which uni-
directionally enters the nucleus. The active transcription factor can interact with
cofactors (red) and turn on transcription. The produced proteins can feedback to
regulate the overall BMP signaling pathway. One protein that is produced is Cv-2
(pink) which can bind BMP ligand and transfer it to the type II receptor. The
receptors on the membrane are also endocytosed and can signal intracelluarly.
91.3.2 Formation of the Extracellular Signaling Complex
In early Drosophila development there is two BMP ligands present in the PV
space: Decapentaplegic (Dpp), a homologue to vertebrate BMP-2 and 4, and
Screw (Scw), a distantly related member of the BMP family within the large
TGF-β superfamily. Dpp is produced over the dorsal 40% of the embryo [17]
and Scw is produced uniformly in the embryo [18]. Dpp and Scw can form ho-
modimers or heterodimers. The Dpp homodimer requires the type I receptor
Thickvein (Tkv) to signal, and the Scw homodimer requires the type I receptor
Saxophone (Sax) [19, 20]. The Dpp and Scw homodimers signal at a low level,
that likely is responsible for specifying that portion of the dorsal surface destined
to become dorsal ectoderm [21]. High levels of BMP signaling are produced by
Dpp/Scw heterodimers. These molecules bind to a heterodimer of type I recep-
tors, Tkv and Sax [21] (Figure 1.2) which in turn, recruit a dimer of the type II
receptor, Punt (Pnt), to form an active signaling complex [22, 23, 24]). Pnt, Tkv
and Sax are all serine/threonine kinases. Once the ligand/receptor complex is
formed, Pnt activates the type I receptors by cross-phosphorylation (Figure 1.2).
During canonical BMP signaling, the type I receptor then phosphorylates a cyto-
plasmic R-Smad (Mad in Drosophila) which in turn, complexes with a common
Smad (Medea in Drosophila). The activated receptors on the membrane can also
10
undergo endocytosis (Figure 1.2). For TGF-β receptors, blocking clatharin medi-
ated endocytosis prevents Smad, activation [25, 26, 27]. By analogy, endocytosis
may also be an important component for activating BMP signaling.
1.3.3 Formation of the Active Transcription Factor
Once the type I receptors phosphorylates Mad to p-Mad [28] (Figure 1.2), two
p-Mads combine with Medea in the cytoplasm and the complex translocates to
the nucleus where it can either activate or repress transcription depending on the
compliment of available cofactors [29] (Figure 1.2). The dynamics of intracellular
Smad trafficking have only been studied using cell culture models and for Smad2 in
response to TFG-β. Lacking more directly relevant in vivo data, I assume in this
discussion that the dynamics of Mad trafficking in response to BMP signals during
Drosophila D/V patterning are similar to those of Smad2 in cell culture systems.
With this caveat, the pMad/Medea complex accumulates in the nucleus through
non-uniform import and export across the nuclear membrane [30] (Figure 1.2).
Mathematical models predict the pMad complex is unidirectionally transported
into the nucleus; whereas, pMad and Medea are transported in and out of the
nucleus with similar rates. The pMad phosphatase, which dephosphorylates pMad
to Mad, is only located in the nucleus. Thus the net effect is an accumulation of
the transcription factor in the nucleus. The net effect of the signaling pathway
11
is to turn on or off genes to specify the formation of different tissues along the
dorsal surface. In chapter 2 of this thesis, I describe the identificationed of a new
mutation in nejire (nej ), a gene encoding a known Smad co-factor and analyze
its effects on D/V patterning.
1.3.4 BMP Signaling in Human Disease
In humans BMP signaling contributes to the formation of limbs, muscle, heart,
kidneys, teeth, and liver. When signaling goes awry it can lead to a wide spec-
trum of developmental defects [31]. For example, loss of BMP signaling during
limb formation can lead to fusion or loss of joints in the digits of the hands and feet
[32]. BMPs were initially discovered by their ability to promote new bone growth
at implantation sites in rats. This finding lead to significant clinical interest and
BMP-2 is now commercially available. It is frequently used to treat traumatic
or degenerative bone injuries. However, there can be significant complications
associated with these treatments that have called its use into question. It is diffi-
cult to prevent BMP-2 from diffusing away from the fracture site, which can lead
to ectopic bone formation at inappropriate sites [33]. It has also been hypothe-
sized that too much BMP-2 at the fracture site may lead to serious infections [33]
and perhaps increased cancer rates. Thus it is important to better understand
how to control BMP diffusion in order to prevent some of these complications.
12
BMP signaling is also essential for cardiac development and vascular angiogenesis
[34]. Up-regulation of BMP signaling is a critical component in cancer metastases
and tumor growth. Inhibition of BMP signaling either directly or indirectly is
an area of research for therapeutic targets to prevent cancer from spreading [34].
BMP signaling is also important for proper kidney development and is expressed
throughout the developing kidney [35]. In the adult kidney is has been shown to
be a protective factor against renal fibrosis and is a target for preventing chronic
kidney disease [36]. To create better targets for treating the diverse range of dis-
eases described above that arise due to aberrant BMP signaling, it is essential to
better understand how BMP signaling is fine tuned during normal development.
1.4 Pattern Formation
1.4.1 BMP as a Morphogen
In the developing embryo, morphogen gradients are one of the ways a homogenous
set of cells is patterned into different tissues, and this mechanisms is conserved
across species [37]. A morphogen gradient determines cell fate in a concentration
dependent manner. During early development, one of the first events is patterning
of the A/P and D/V axes by morphogen gradients. This is a critical step in
development because it determines the foundations for the body plan that will
13
follow. In D/V axis patterning, BMP ligands are major morphogens important
for specifying dorsal structures [38]. BMP is a morphogen because it forms a
gradient on the dorsal surface and specifies at least four different regions of gene
expression at different thresholds of signaling [39, 29, 38, 40] (Figure 1.3).
One of the most common analogies for how morphogens specify pattern through
gene regulation is known as the French flag model [41]. In this model, cells (or nu-
clei in the case of an early Drosophila embryo) determine what genes are expressed
by reading the concentration of the morphogen outside the cell. In Drosophila em-
bryos, the highest level of BMP signaling specifies the amnioserosa, a tissue which
is required for dorsal closure later in development [42] (Figure 1.3). Moderate lev-
els of BMP specify the dorsal epidermis [38]. Within the dorsal epidermis there
are at least three distinct gene expression thresholds that may act to further sub-
divide the epidermis into smaller unique units of development[39] (Figure 1.3).
Despite much research aimed at elucidating the mechanism of BMP gradient for-
mation it is still not fully understood, nor is it entirely clear how nuclei interpret
the gradient to specify distinct tissue boundaries.
The French Flag model for how morphogen gradients act during tissue spec-
ification is obviously an oversimplification, since the patterning system must be
able to compensate for genetic and environmental variability to reproducibly con-
struct a functional embryo. If these variables produce any noise in morphogen
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concentration or readout it could have a large effect on the position of bound-
aries. Lewis Wolpert, the founder of the French Flag Model, has proposed that
there must be a mechanism for cell-cell communication during the formation of
boundaries [43] to ensure their proper placement. However, during dorsal surface
patterning there is no evidence of direct nuclei to nuclei communication to create
these boundaries. Thus the boundaries are assumed to be determined from read-
ing the concentration of the morphogen ligand, but the mechanism of how this
happens is not clear.
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Figure 1.3: Morphogen Gradient Model - A morphogen gradient of BMP ligand is
formed on the dorsal surface of the embryo. Zero represents the dorsal midline and
1 represents the lateral edge of the dorsal surface. High concentrations of BMP
ligand specify the amnioserosa (purple) and lower levels specify the dorsal epider-
mis (turquoise). The dorsal epidermis is further subdivided into different regions
depending upon the concentration of BMP ligand. The dotted lines represent the
thresholds determining different boundaries between tissues.
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1.4.2 Formation of the BMP Morphogen Gradient in the
Early Drosophila Embryo
In the early embryo, the Dpp gradient is formed through interactions with extra-
cellular modulators in the PV fluid. Dpp is produced and secreted into the PV
space at uniform levels over the dorsal half of the embryo. However pMad, the
downstream signal of BMP, follows a graded profile that starts wide and contracts
over time to a narrow domain centered on the dorsal midline [44]. Thus, it is pre-
sumed that a gradient of Dpp is formed in the PV space that follows the gradient
seen in pMad. The Dpp gradient is formed through a diffusion based mechanism
in the PV space. The present model for how the sharpening of the dpp gradient
occurs is as follows. First, Dpp forms a heterodimer with another BMP ligand
Scw. In vitro studies show that this heterodimer is much more potent than ei-
ther homodimers for producing high levels of pMad. The Dpp/Scw complex then
binds to type IV collagen. Type IV collagen forms a scaffold for forming a complex
that ultimately facilitates long range diffusion of Dpp/Scw [45, 46] (Figure 1.4).
The levels of Dpp in the PV space are hypothesized to be low, so the type IV
collagen may help to concentrate the ligand to increase its effective binding rate
to Short Gastrulation (Sog), a BMP inhibitor that blocks the ability of BMP to
bind to receptor. Sog binds to Dpp/Scw on collagen to form a Dpp/Scw/Collagen
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tripartite complex (Figure 1.4). Upon Sog binding Dpp, Dpp is dislocated from
type IV collagen and replaced with Sog binding the tripartite complex to type
IV collagen (Figure 1.4). Then Twisted Gastrulation (Tsg) binds to the complex
and dissociates it from type IV collagen allowing the Dpp/Scw/Tsg/Sog com-
plex to diffuse and not rebind to collagen or receptor [46, 21] (Figure 1.4). The
Dpp/Scw/Tsg/Sog complex also lengthens the lifetime of Dpp in the PV space by
protecting it from receptor mediated degradation [47, 48]. The metalloprotease
Tolloid (Tld) cleaves Sog and releases Dpp/Scw to either signal or rebind to BMP
binding proteins [49, 50] (Figure 1.4). Sog levels are highest in the lateral domain
of the embryo, which preferentially leads to transport of Dpp/Scw toward the
dorsal midline [47, 51]. Tld levels are highest on the dorsal midline [49]. This fa-
vors the release and accumulation of Dpp/Scw on the dorsal midline. The overall
binding rate for Dpp to its receptor is relatively low. In the absence of Sog type
IV collagen may help transfer Dpp to its receptor [45, 46]. This complex set of
reactions in the PV space allows for a gradient of Dpp/Scw to be formed with
peak expression along the dorsal midline.
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Figure 1.4: Model of the Formation of the Dpp/Scw Gradient - Dpp (pink) binds
to type IV collagen (purple). Sog (brown) binds to Dpp/Collagen complex. When
Scw binds to the complex, Dpp is released and Sog binds to collagen. Then, Tsg
(green) binds to the Dpp/Scw/Sog complex and releases it from type IV collagen.
The Dpp/Scw/Sog/Tsg complex can diffuse in the PV space. Tld (black) can
release Dpp/Scw from Sog/Tsg. Dpp/Scw can rebind to collagen IV, which can
help transfer it to its receptor complex of Tkv (red), Pnt (blue), and Sax (purple).
Figure modified from [46].
The Dpp/Scw gradient is primarily studied by examining pMad expression
profiles. Despite many production attempts, no high affinity antibodies exist to
study Dpp in the PV space. Dpp-Green Fluorescent Protein (GFP) fusions have
been generated to study Dpp profiles in the PV space. The Dpp-GFP fusions
can rescue Dpp null embryos, but the GFP cannot be directly visualized in the
PV space. The failure of directly visualizing Dpp-GFP in the PV space may be
caused by the time delay required to form a functional chromophore. The half-life
of GFP folding is estimated to be about 30 minutes and the formation of the Dpp
gradient occurs at a similar rate. One work around that has been identified is
that antibodies against GFP can be injected into the PV space, enabling the Dpp
gradient to be visualized [22]. However this method is technically very difficult,
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so the typical method for visualizing BMP gradient formation is indirect and
involves examination the distribution of pMad since a high quality antibody is
commercially available (Figure 1.5).
Early Late 
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Figure 1.5: pMad Expression Profiles During Early and Late Embryogenesis -
pMad profiles of the dorsal surface during early (A) and late (B) embryogenesis.
Embryos are oriented with anterior to posterior from left to right. pMad profiles
start broad and at low levels in the early embryo (A). In the later embryo, pMad
profiles are narrower and more intense along the dorsal midline (B).
The boundaries between high and low signaling of the embryo are fairly sharp
(Figure 1.5). The nuclei follow a fairly smooth gradient between high and low
signaling. In wild type embryos, there is never a nucleus with high pMad levels
in a region of nuclei with low pMad levels. The patterning of the embryos is also
fairly consistent between embryos. This is somewhat surprising since the levels
of Dpp required to achieve full activation of BMP signaling lead to an estimate
of in vivo concentration to be on the order of 10-100 molecules / nucleus. Thus,
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for such consistent and robust patterning to occur, there must be mechanisms to
dampen any stochastic fluctuations due to low numbers of Dpp/Scw in the PV
space. I will use mathematical modeling to study mechanisms that allow for this
smooth output of pMad expression profiles in chapter 3.
1.4.3 Feedback in Forming the BMP Morphogen Gradient
In the early blastoderm, p-Mad concentration profiles are moderate and wide
within the dorsal domain (Figure 1.5 A). In the late blastoderm, Dpp protein
accumulation intensifies and contracts to a 5-9 nucleus wide dorsal stripe [44, 50]
(Figure 1.5 B). The first models for D/V patterning predicted an intensification
and widening of BMP signaling on the dorsal surface [47, 51]. Wang and Fer-
guson proposed that a positive feedback loop that increases the amount of BMP
signaling in a local area could account for both the contraction and intensification
of signaling [22], and mathematical models have confirmed that this could work
[52]. The two best hypotheses for a positive feedback molecule that upregulates
signaling is a co-receptor the preferentially binds BMP ligands and transfers it to
the BMP receptor or a co-factor that directly upregulates the BMP receptors or
their activity. Wang and Ferguson further speculated that feedback of a negative
regulator of BMP signaling in the lateral regions of the embryo could also help to
account for the contraction of signaling. However, the downstream targets that
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give rise to the feedback in the embryo system have not been identified.
1.4.4 Comparison of BMP Signaling in Dorsal / Ventral
Patterning in Early Embryogenesis and the Wing
Disc
A clue to possible modulators that could account for the contraction and intensifi-
cation in D/V patterning comes from analysis of BMP signaling during crossvein
formation in the wing disc. The wing imaginal disc is a group of mitotic cells
contained in the Drosophila larva that will form the adult wing during metamor-
phosis. During metamorphosis, two wing tissue types are formed the wing proper
and the veins which act as structural rods to stiffen the wing so that flight is pos-
sible. There are also two types of veins; five longitudinal ones that run parallel to
the proximal/distal axis and two crossveins which run perpendicular to the longi-
tudinal veins (Figure 1.6). A high level of BMP signaling is required for formation
of all veins (Figure 1.6) but the mechanism of crossvein formation is particularly
interesting since they require a shuttling mechanism similar to what occurs in the
early embryo [40]. However, there are some notable differences between the two
systems. In D/V patterning the morphogen gradient is created within a region
of uniform Dpp production; whereas in the crossvein the morphogen gradient is
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created by diffusion away from Dpp produced in the longitudinal veins (Figure
1.6). Heparan sulfate proteoglycans (HSPGs) have been shown to be crucial for
BMP signaling in the wing disc [53]. However, HSPGs are not required during
embryonic dorsal surface pattering. In fact there is a translational block that
prevents HSPGs from being expressed during the first three hours of development
and ectopic HSPG expression actually disrupts D/V patterning likely by seques-
tering too much BMP into non-signaling complexes [54]. Two other genes that
are needed for proper wing patterning but not D/V patterning are Pentagone,
and Larval translucida (Ltl). Both code for proteins that bind to HSPGs and
modulate BMP signaling through ill-defined processes but neither is expressed at
high levels in the embryo [55, 56]. Interestingly, Ltl does genetically interact with
a third protein that has been identified as essential for crossvein formation known
as Crossveinless 2 (Cv-2) (Figure 1.6). Cv-2 is expressed in the early embryo and
has also been shown to be a secreted factor that can bind to both BMP ligands
and receptors [57]. Furthermore, Cv-2 expression is induced by BMP signaling
potentially enabling it to be a feedback component that sharpens BMP gradients.
Indeed, theoretical models that incorporate Cv-2 into the signaling paradigm as
a molecule that acts as an exchange factor can generate the enhanced and sharp-
ened gradients that are observed in the early embryo [52, 40, 57] (Figure 1.2). In
this thesis I will examine the role of Cv-2 in dorsal surface patterning in Chapter
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2.
Figure 1.6: Crossvein Formation in the Wing Disc - pMad is expressed along
the future position on the 5 longitudinal veins and 2 crossveins (A and B). In
the posterior crossvein (PCV) pMad expression starts broad (A) and refines over
time to the future position of the PCV (B). Dpp mRNA is not expressed in the
region of the PCV (C) and must diffuse into the PCV region (E). Cv-2 mRNA
is expressed in a pattern that mimics pMad expression (D). The gradient of Dpp
in the PCV is formed using many of the same molecules involved in the Dorsal
Surface Dpp gradient (E). However unlike dorsal surface Dpp gradient formation,
in the PCV the gradient is formed from Dpp in the longitudinal veins (E). Figure
modified from [40].
1.5 Stochasticity in Biological Systems
Embryonic development has a remarkable property of being extremely robust, i.e.
reliable and reproducible, despite fluctuations in the environment surrounding
the embryo, noise in genome expression, and variations in the composition of the
proteome. Despite these complications, the hatch rate of Drosophila, embryos is
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nearly 80-90% in a laboratory setting [58, 59]. As the embryo matures into an
adult some of the same issues still persist on a genetic, cellular, and organism
level [60, 61, 62, 63]. The role of stochasticity in biological organisms is also
important for understanding the development of disease processes [64] and how to
increase efficacy and decrease side effects in drug discovery [60]. In order to better
understand the stochastic nature of cells more work is needed to quantify the
dynamics and concentrations of signaling molecules and to elucidate mechanisms
of how cells adapt to or exploit noise.
Stochasticity in biological systems can occur at many different levels. In D/V
patterning noise can come from low concentrations of BMP signaling molecules
in the PV space leading to randomness of molecules interacting [61]. In the cyto-
plasm, stochasticity can arise from the randomness of pMad and Medea molecules
interacting to form an active transcription factor. Noise can also arise from the
process of transcription. Fluctuations in transcription are one of the most well
studied areas of intracellular noise [61, 65, 66]. There can be noise in turning
on and off gene expression, which can lead to a burst of mRNA molecules and
downstream noise in the levels of protein produced. The contribution of noise to
all levels of the BMP signaling cascade has not been carefully studied, nor have
mechanisms that may enhance or decrease the inherent noise in the system been
examined.
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1.6 Feedback Loops in Signaling Networks
Signaling pathways are regulated at almost all levels and in many different ways.
One common mechanism of regulation is positive and negative feedback of the
signaling network on to itself. In positive feedback, an initial signal amplifies itself
through modulation of the activity of one of the signal transduction components.
In negative feedback the opposite occurs. Depending upon how positive and
negative feedback loops are connected, a wide range of dynamic behaviors can
be found. Bistability, defined as having two stable steady states, can be created
from either a positive feedback loop or a double negative feedback loop [67]. A
negative feedback loop can help to stabilize a protein at a constant level [67]. In
a noisy environment, negative feedback is also a mechanism that can reduce noise
[68, 69]. Under the right conditions, negative feedback loops can also create stable
sustained oscillations [67]. In biology we can determine the structure of signaling
networks, which often contain complex feedback loops. However, knowing the
general structure of the networks does not allow us to easily predict the dynamics.
Mathematical modeling can be used to predict the dynamics that are possible in
different signaling network configurations.
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1.7 Modeling in Dorsal / Ventral Patterning
1.7.1 Previous Models of Dorsal / Ventral Patterning
Mathematical modeling has been an important tool for understanding develop-
mental biological systems. In D/V patterning, models have served a critical role
for understanding the output of complex regulatory systems. A good model both
explains the data and suggests new areas of study. In D/V patterning, three differ-
ent types of models have been examined with respect to BMP signaling. The first
set of models focused on describing mechanisms that helped direct the transport
of Dpp within the PV space through specific interactions with other extracellu-
lar proteins, such that a steep gradient of Dpp developed at the dorsal midline
[70, 47, 52]. Based on what was known at the time concerning the molecules in-
volved and their biochemical activities, these models revealed that, something was
missing in the model formulation since they could not explain the observed con-
traction and intensification of Dpp signaling along the dorsal midline. A second
stochastic model addressed the issue of low levels of BMP signaling molecules and
predicted that noise could be diminished in this system if there were a large num-
ber of receptors on the membrane surface [71]. However, this model did not look
at factors downstream of the BMP receptors to see if there were other mechanisms
that could also dampen the noise arising from low levels of signaling molecules. A
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third model focused intracellularly on the Smad proteins and was primarily aimed
at describing how nuclear accumulation of the Smad proteins occurs through an
asymmetrical transport rate in and out of the nucleus [30]. As a component of this
thesis I aim to integrate all the current models of BMP signaling into one model
to examine how noise propagates through the BMP signaling network (Chapter
3). Through this study I hope to determine how the BMP signaling pathway con-
sistently patterns the Drosophila embryo with sharp boundaries between areas of
high and low pMad signaling as seen in Figure 1.5.
1.7.2 Stochastic Modeling of Dorsal / Ventral Patterning
Most of the models for BMP signaling have been based on deterministic differential
equations. In these models the morphogen concentrations at particular points in
space can be described over time using the partial differential equations:
∂2X
∂t
= D∇2X +R(X) (1.1)
where X is a molecule in the system, D∇2X represents diffusion of species X,
and R(X) is a function containing the reactions of species X. If diffusion in the
system is not taken into account, the description reduces to ordinary differential
equations with just the reaction terms remaining. However, if noise is present in
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the system, stochastic differential equations may be important to consider. Deter-
ministic equations assume that large numbers of molecules are present, and that
they follow the overall average behavior of the molecules through mass action
kinetics. In stochastic equations, individual molecules are followed, and their be-
havior is described by a chemical master equation. If significant noise is present,
these models can lead to different predicted behavior. In a system with multiple
steady states, based on a set of initial conditions, the deterministic equations will
normally give the same steady state solution. However with stochastic equations,
the same set of initial conditions can lead to multiple different steady state so-
lutions due to the noise in the system. Even in the case of one steady state in
the system, a stochastic system can lead to a spread of solutions around a steady
state as a result of noise in the system.
Noise due to low levels of signaling molecules could significantly influence the
ability of the system to reproducibly generate a consistent gradient of BMP sig-
naling. If there is noise in creating a gradient of BMP signaling, this may affect
now nuclei determine their position along the D-V axis and may make sharp
boundaries difficult to form. Thus, we propose that there must exit mechanisms
to decrease noise in the system to create sharp reproducible boundaries of gene
expression, and to study this we will create a stochastic model of BMP signaling
that is based on previous deterministic models.
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The stochastic nature of the system can be modeled with a Markov chain
model. Let X(t) = [X1(t), X2(t), . . . , Xm(t)] be the number of molecules of each
species in the system. X(t) is a continuous time Markov chain if for any 0 < s0 <
s1 < . . . < sn < s and possible states i0, . . . , in, i, j we have
P (X(t+s) = j|X(s) = i,X(sn) = in, . . . , X(s0) = i0) = P (X(t+s) = j|X(s) = i).
(1.2)
This means that the probability of a reaction happening is independent of
the history of the previous states. The Markov chain model for chemical reactions
approaches the deterministic formulation for the system of reactions in the infinite
volume limit of the Markov chain model [72]. If X(t) is a Markov chain, then it
satisfies the Chapman-Kolmogorov equation
p(x(tn), tn|x(tn+2), tn+2) =∫
p(x(tn), tn|x(tn+1), tn+1)p(x(tn+1), tn+1|x(tn+2), tn+2)dx(tn+1) (1.3)
where x(tn), x(tn+1), and x(tn+2) are X(t) at times tn, tn+1, and tn+2 respectively.
This equation states that the probability of going between x(tn) and x(tn+2) is
the integral of all paths going from x(tn) to x(tn+1) and then x(tn+1) to x(tn+2)
for all x(tn+1).
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From the Chapman-Kolmogorov equation, we can derive the chemical master
equation which governs the evolution of the probability that the system will be
in a particular state as a function of time. The chemical master equation can be
used to follow how the system evolves stochastically over time. For a system with
R reactions and X species, the chemical master equation is
dP (X(t), t)
dt
=
∑
r∈R
ar(X − νr)P (X − νr, t)−
∑
r∈R
ar(X, t) (1.4)
where νr is the stoichiometric vector of reaction r and ar(X) is the reaction propen-
sity of reaction r. The stoichiometric vector describes how the molecules of X(t)
change during the reaction. For example, for the reaction x1 + x2 
 x3, the stoi-
chiometric vector for the forward direction is [−1,−1, 1] for the vector [x1, x2, x3].
The reaction propensity describes how likely it is that a reaction will occur. For
a first order reaction, ar = krx where kr is the kinetic rate constant. For a second
order reaction where xi 6= xj, ar = V krxixj where V is the volume of the system.
For a second order reaction where i = j, ar = V krxi(xi−1)/2. The chemical mas-
ter equation is a coupled set of ordinary differential equations (ODE) with one
equation for every possible combination of molecules in the system. When there
are no fluctuations in X(t), the chemical master equation reduces to a continuous,
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deterministic differential equation
dX(t)
dt
=
R∑
r=1
νrar(X(t)). (1.5)
1.7.3 The Gillespie Algorithm
For a large system, the chemical master equation can have too many states to
solve. Therefore simulations must be done to simulate a system based on the
chemical master equation. The reactions in a stochastic biological system can be
simulated using the Gillespie algorithm [73, 74]. In the Gillespie algorithm, all
molecules and their positions are tracked over time. All reactions that occur are
either unimolecular or bimolecular. Trimolecular reactions and larger must be
broken down into a series of unimolecular or biomolecular reactions. This method
assumes that the system is well mixed. The following steps describe the Gillespie
algorithm:
1. Initialize the time t = t0 and the system’s state x = x0.
2. Evaluate each reaction propensity, ar(x), for all r ∈ R and find their sum,
a0 =
∑R
j=1 aj(x). a0 is needed to find the time the next reaction will occur.
3. Generate p1 and p2 which are random numbers from URN[0, 1].
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4. Find the next time a reaction will occur, which is at t + τ where τ =
1
a0(x)
ln( 1
p1
).
5. Find the next reaction that will occur by finding j, where j is the smallest
integer that satisfies
∑j
i=1 aixi > p2a0(x). j is the next reaction that will
occur. This step is a way of randomly selecting the next reaction to occur
from all possible reactions.
6. Update the time and the reaction that occur by replacing t ← t + τ and
x← x+ νj.
7. Iterate again, starting at step 2. The time steps for the Gillespie method
are on the order of 1
a0(x)
. a0(x) is often quite large which can make the
simulations very slow.
The Gillespie algorithm needs to be modified to allow for it to be used in
a system that is not well mixed. In this case, diffusion of molecules must be
taken into account. A system can be broken into smaller compartments, where in
each compartment the molecules are well mixed. Then diffusion can be treated
like a chemical reaction in the Gillespie algorithm for moving between different
compartments. For example, for a system of length L, we can break it up into M
equally sized compartments of length h = L
M
. The probability of moving between
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compartments, di, for the ith molecule in the system with a diffusion constant of
Di is di =
Di
h2
.
1.7.4 Project Aims
In this thesis, I report on two studies aimed at understanding different aspects
of BMP signaling as it relates to early D/V patterning in Drosophila. In the
first project I examined the possible contribution of two genes to feedback control
of BMP signaling during dorsal surface patterning. I identified a new allele of
Nej, a protein that is thought to help the Smad complex form a more robust
transcription factor in regions of high BMP signaling. I found that loss of Nej
leads to variable BMP signaling output and discuss how this might occur. I also
studied the role of Cv-2, a surface localized BMP binding protein, during D/V
patterning and found that it acts in a negative feedback loop to inhibit BMP
signaling. Cv-2 may also increase the amount of noise in BMP signaling during
D/V patterning. The description of these projects is found in chapter 2. In a
second project, I helped to create a novel three dimensional stochastic model to
study how stochasticity might impact BMP signaling. In this model I integrated
membrane, cytoplasmic, and nuclear dynamics of BMP signaling components to
learn how noise might propagate through the system. The analysis of this model
is found in chapter 3. Chapter 4 provides an overall discussion of the conclusions
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reached by these studies.
Chapter 2
Crossveinless-2 and Nejire
Modulate BMP Signaling
2.1 Introduction
The Bone Morphogenic Protein (BMP) signaling pathway is highly conserved
and used in many developmental processes including embryonic axis specification,
organogenesis and apoptosis. Embryonic axis specification is a critical first step in
determining the developmental framework for the entire body plan. This process
must be extremely robust and able to buffer against both extrinsic environmental
variability during development and intrinsic genetic differences between individual
embryos. This is especially true in Drosophila melanogaster as embryos undergo
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external development, so they must be able to withstand a significant variation
in environment conditions such as temperature and hydration state. In order to
consistently pattern the embryo correctly in the face of these naturally occurring
variations, there must be mechanisms that ensure robust development.
The dorsal surface of the Drosophila embryo is patterned by a morphogen
gradient of Decapentaplegic (Dpp), a BMP family member [39, 29, 38, 40]. In
this case Dpp is thought to act as a morphogen because it patterns the surface in
a concentration dependent manner [39, 29, 38, 40, 21]. Dpp is produced uniformly
over the dorsal surface of the embryo [17]. The Dpp gradient is formed through
a series of extracellular modulators that shuttle Dpp to the dorsal midline [40].
Production of phosphorylated Mad (pMad), the intracellular transducer of the
Dpp signal, is initially produced in a broad region within the dorsal domain of
the early blastoderm embryo, but rapidly contracts and intensifies to a 5-9 nuclei
wide stripe during nuclear divisions 12-14 [44, 50]. Peak signaling in the dorsal
most 5-9 cells specify the amnioserosa, a tissue that is needed for coordinating
gastrulation and proper dorsal closure later in development [42]. In the dorso-
lateral regions of the embryo, that see a lower level of BMP signaling, the dorsal
epidermis is specified [38, 21]. The boundary between high and low levels of
signaling is very precise and forms a sharp border. In dorsal surface patterning
no evidence has been found of nuclei to nuclei communication to help sharpen
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this border. Instead the nuclei must interpret the concentration of Dpp in the
perivitelline (PV) space, the region of the embryo above the plasma membrane.
How the embryo robustly creates the boundary between the amnioserosa and
dorsal epidermis is not completely understood.
During dorsal surface patterning, BMP signaling leads to changes in gene
transcription. Some target genes produce products that directly help specify the
features of the particular fated tissue and others appear to be involved in feedback
signals that modulate BMP signaling. The primary BMP ligand in specifying dor-
sal tissue fate is Dpp, a homologue to vertebrate BMP-2 and 4 [40]. Dpp forms a
heterodimer with Screw (Scw) (Dpp/Scw), a distantly related BMP family mem-
ber [40, 75, 21]. Both Dpp and Scw are members of the TGF-β superfamily.
The Dpp/Scw heterodimer primarily signals through a heterotetrameric complex
composed of two type I and two type II serine/threonine receptors to phosphory-
late Mad to pMad [28]. Two pMads combines with a co-smad Medea to form an
active transcription factor [29]. The pMad/Medea complex interacts with other
co-transcription factors to either turn on or off gene transcription. Some of the
genes pMad/Medea controls may produce proteins that feedback to either inhibit
or enhance BMP signaling. Although the major components of BMP signaling
have been identified, we still do not understand the fine control of BMP signal-
ing. Through studying the robustness of dorsal surface patterning we will better
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understand the modulation of BMP signaling.
To understand robustness of dorsal surface patterning I identified two genes
that may disrupt the consistent patterning of the embryo. I found a new mutation
in the gene nejire (nej ) that leads to a highly variable phenotype during dorsal
surface patterning. I also studied the gene crossveinless-2 (cv-2 ), which has been
examined during wing disc patterning [76, 57] and proposed as a robustness mech-
anism for BMP signaling [71]. It has been shown that cv-2 is expressed during
dorsal surface pattering [57], but the Cv-2 phenotype has not been characterized.
2.1.1 The Role of Nejire in the BMP Signaling Pathway
In order for feedback in Dpp signaling to occur, an active transcription factor
must be formed to turn on transcription. The basic structure of the Dpp tran-
scription factor is two pMad molecules and a co-smad Medea. However, additional
co-factors can assemble with the pMad/Medea complex to turn on or off specific
genes. One of the co-factors for BMP signaling is Nej, a CREB binding protein
(CBP) / p300 protein that acts as a general co-activator or inhibitor of tran-
scription factors during development [77, 78, 79]. In most cases Nej acts as an
activator of transcription. However Nej inhibits Wnt/Wingless signaling through
acetylating a conserved lysine residue on Drosophila T-cell Factor [78]. In the
early embryo Nej is an activator interacting with both Dorsal and Dpp to activate
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ventral and dorsal surface patterning [77].
Nej is required for proper Dpp signaling during dorsal surface patterning,
midgut development, tracheal patterning, and wing development [80]. Nej func-
tions in a very region specific manner to control gene expression. In dorsal surface
patterning, the activity of peak signaling of Dpp specifies the amnioserosa, and in
this region both race and hindsight expression is lost. However in regions adja-
cent to the presumptive amnioserosa, race and hindsight expression is preserved
[80, 39]. Nej does not affect patterning of the neurogenic ectoderm. Nej acts as
a co-activator of the pMad/Medea complex through the C-terminal region of Nej
binding to the C-terminal MH-2 region of Mad [80]. The N-terminal MH-1 region
of Mad acts as an inhibitor of Nej binding [80]. Nej also regulates the transcrip-
tion of scw, twisted gastrulation (tsg), and tolloid (tld), all of which are necessary
for forming the Dpp morphogen gradient [81]. However Nej does not regulate all
of the proteins required for Dpp gradient formation, as short gastrulation (sog) is
not under the control of Nej [81]. Thus Nej acts in a region specific manor with
Mad to activate transcription for regions of high signaling during dorsal surface
patterning.
Nej serves several roles to promote transcription. The acetyltransferase activ-
ity of Nej promotes the activation of p-Mad through acting as a histone acetyl-
transferase to open the chromatin for transcription. Nej acetylates all four histones
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[82] both directly [82, 83] and indirectly through combination of other acetyltrans-
ferases [84, 85, 86]. However Nej can also promote the formation of chromatin
through acetylating Histone H3 Lysine 56 [87]. Nej also acts as a scaffold or bridge
for other chromatin modifiers to assemble into an active transcriptional complex
[88]. Since a wide range of proteins for several different signaling pathways in-
teract with Nej, it may serve as an integrator between signaling pathways [88].
Nej may also acetylate other transcription co-activators in the complex. The wide
range of functions Nej plays in the nucleus may allow Nej to interact in complex
ways to turn on transcription in areas of high levels of Dpp signaling.
2.1.2 The Role of Crossveinless-2 in the BMP Signaling
Pathway
Crossveinless-2 was first discovered in Drosophila [76] and has a vertebrate ho-
molog BMPER and a related protein Kielin [89, 90, 91, 92]. Cv-2 is a secreted pro-
tein that has a N-termial cystine rich domain for BMP binding and a C-terminal
von Willebrand Factor domain for membrane tethering [76]. The knockout and
overexpression phenotypes were fairly perplexing until the mechanism of action
was discovered. Cv-2 has been proposed to be both an activator [93, 94, 95, 91]
and inhibitor [96, 97, 98, 99, 89, 92] of BMP signaling. Low expression of Cv-2
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can promote signaling and overexpression can inhibit it. One proposed molecular
mechanism of action for Cv-2 is that it binds BMP ligand and then transfers it
to the type I BMP receptor, Thickveins (Tkv) [57]. Depending upon the relative
binding rate of ligand to Cv-2 or its receptor and the transfer rate of BMP from
Cv-2 to its receptor, Cv-2 can act as an inhibitor or activator of signaling by either
sequestering or transferring ligand. Unlike many of the extracellular modulators
of BMP signaling, Cv-2 acts locally to enhance or inhibit BMP signaling [57].
In Drosophila, Cv-2 has been primarily studied in the wing disc, a larval tissue
that forms the adult wing. In the wing disc, a gradient of BMP diffusing from
the longitudinal veins specifies the location of the crossveins [40, 76, 57, 100]. In
Cv-2 null adults the crossveins are missing indicating that Cv-2 in this context
enhances BMP signaling. In the posterior crossvein, Cv-2 is required to both
initiate and sustain pMad expression. In the wing disc, Cv-2 is secreted and is
indirectly attached to the cell surface through binding to heparin sulfate proteo-
glycans (HSPGs) via its vonWillibrand Factor domain located at the C-terminus.
As described above, Cv-2 can also bind to the BMP type I receptor Tkv but
the relative strengths of the interaction between the two binding partners is not
known. In the early embryo HSPGs are not produced because of a translational
block [54]. As a result, Cv-2 may not be as strongly tethered to the membrane
surface as it is in wing imaginal tissue. Since the activity of Cv-2 (either pro BMP
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or anti BMP) is highly context dependent, it is difficult to predict a priori how
Cv-2 will affect BMP signaling during embryonic dorsal surface patterning.
Mathematical modeling of Cv-2 function during dorsal surface patterning has
proposed that it may help shape the Dpp gradient through local activation of
Dpp signaling [52, 57] and by increasing robustness of the signaling response in
the face of potential fluctuations in Dpp protein levels [71]. During dorsal surface
patterning, pMad profiles both contract and intensify along the dorsal midline due
to a series of interactions between the Dpp/Scw heterodimer and various binding
partners as well as the protease Tld. The end result of these interactions is a
net flux of Dpp/Scw from the lateral regions toward the midline [44]. However
based on the presently identified proteins and their known biochemical activities,
mathematical models predict a widening and intensification of BMP signaling
[70, 47] with time which is the opposite of what is actually observed. It has been
proposed that a positive feedback circuit is needed to sharpen and intensify the
pMad pattern [22]. The identity of the molecule(s) that provide the feedback is
presently unknown, but modeling has shown that a cell surface localized BMP
binding protein such as Cv-2 that can transfer BMP to its receptor can provide
the necessary boundary sharpening and pMad intensification [52]. A second issue
concerns the robustness of the system. Under most conditions, the D/V patterning
mechanism is very robust even through estimates from cell culture data suggests
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that the number of BMP molecules on the dorsal surface may be in the range of
10-100 molecules per nucleus [50]. This low number might be expected to result
in stochastic fluctuations in the amount of signal perceived by each nucleus, which
could make it hard to reliably pattern the dorsal surface. Mathematical models
have demonstrated that a molecule with Cv-2 like activities could also function
to dampen any stochastic fluctuations in BMP signaling [71]. Thus inclusion of a
Cv-2 like molecule into the mathematical models helps reduce stochastic noise and
solves the intensification and contraction problem inherent in the original models.
In this chapter, I will examine experimentally how BMP signaling is modulated
in the early embryo by the transcription factor Nej and the BMP binding molecule
Cv-2. I have identified a new allele of nej, and characterized its phenotype with re-
spect to D/V patterning. I demonstrate that this allele causes extreme variability
in formation of the pMad stripe suggesting that Nej may be essential for buffering
noise. I will also show the effect on Cv-2 loss on the contraction and intensifica-
tion of BMP signaling on the dorsal surface of the Drosophila embryo. I find that
Cv-2 is induced by BMP signaling consistent with a potential feedback role but
its loss does not dramatically affect pMad sharpening or intensity suggesting it
is not likely to be the molecule that provides the positive feedback necessary to
get proper dorsal patterning. As part of this study, I have also demonstrated the
necessity for careful controls when analyzing subtle patterning phenotypes and
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identified the best methodology to use for obtaining reproducible results.
2.2 Results
2.2.1 Nej Identification and Characterization
I received the Maternal Ventralizing Factor-1 (Mvent1) fly line as a gift from
Armen Manoukian. Mvent1 contains a lethal mutation on the X chromosome
that is hypothesized to create a dorsal surface patterning defect. A homozygous
loss of function allele is lethal, but a stable stock can be maintained with the X
balancer chromosome FM7. I have identified Mvent1 as a new mutation in the
gene nejire (nej ). The Mvent1 phenotype is highly variable ranging from no effect
on D/V patterning to strongly ventralizing.
Identification of Nejire Mutation
I mapped the location of the mvent1 mutation using two different techniques.
First, we used a duplication mapping technique (Figure 2.1). A series of dupli-
cations containing segments of the X chromosome transposed to the 3rd or Y
chromosome was obtained from the Bloomington Stock Center. Males from these
stocks were crossed to mvent1 balanced females and the progeny were examined
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for presence of non-balanced (rescued) males [101, 102]. 80% of the Blooming-
ton duplication series was used, but no rescue was observed. As an alternative
mapping strategy, I next used a P-element mapping technique to find the general
region of the mutation (Figure 2.2). In this method, the recombination frequency
between a white (w+) containing P-element inserted on a wild type chromosome
and a gene of interest (mvent1) on a w− background will give a rough estimate
of the distance between the P and the mutant gene. (Figure 2.2). The closer the
mutation is to the P-element, the less likely the recombination event will occur be-
tween them. A rough P-element mapping narrowed the region containing mvent1
to a location between the cytological interval 8A-10E (Table 2.1). A finer map-
ping narrowed the region to the cytological interval 8E7-9A1 with the most likely
region being at 8F9 (Table 2.2). There are 18 genes located between 8E7-9A1.
Nine genes have moderate to very high expression levels in the early embryo based
on modENCODE temporal expression data, and two genes had no information.
The two genes in the region 8F9 with high modENCODE expression data are
lethal (1)GO232 (l(1)GO232 ) (8F2-8F6) and nejire (nej ) (8F7-8F9). L(1)G0232
is a non-membrane spanning tyrosine phosphatase, and Nej is a histone acetyl-
transferase known to interact with pMad [80]. Thus using P-element mapping I
narrowed the search for the mutation to a small list of candidate genes, one of
which included a gene known to interact with the BMP signaling pathway.
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Figure 2.1: Duplication Mapping Technique- Virgin female (pink) flies containing
a chromosome with the mutation (red star) and a balancer chromosome (grey) are
crossed the males (blue) containing a duplication of the X chromosome (green).
Males are scored for eye shape. Males with the balancer chromosome have bar
eyes, whereas rescued males will have normal eyes.
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Figure 2.2: P-Element Mapping Technique- Virgin females (pink) containing the
mutation (red star) in a w− background and a balancer chromosome in a w−
background (grey) are crossed to males (blue) with a P-element containing the
w+ gene (green). The F1 progeny are sorted for females containing normal eyes
and crossed to F1 progeny males. The males from the F2 progeny are scored for
the number of males with red eyes (no recombination) and males with white eyes
(recombination occurred). The closer the mutation is to the P-element the less
likely recombination will occur.
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Region Stock % White Total Counted
1-0 (1A) 36539 27.4% 259
1-6 (4A) 33304 25.0% 340
1-12 (5A) 19277 16.9% 201
1-18 (6C) 26611 14.7% 285
1-24 (8A) 22596 5.35% 636
1-30 (9A) 32651 0.456% 4825
1-36 (10E) 20044 5.87% 732
1-42 (11E) 10113 8.55% 269
1-48 (12E) 19646 10.4% 229
1-54 (14D) 15830 22.5% 200
1-60 (17A) 11444 30.0% 203
1-66 (20A) 33445 20.2% 332
Table 2.1: Rough P-Element map- A rough P-element map was performed us-
ing fly lines with P-elements equally spaced across the X-chromosome. A lower
percent white eyes indicates the p-element is closer to the mutated gene. A re-
gion was identified between the cytological region 8A (5.4% white eyes) and 10E
(5.8% white eyes) with a hotspot at 9A where there is only 0.46% white eyes. The
rough mapping only has one hotspot indicating there are not two widely separated
regions that have a lethal mutation.
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Region Stock % White Total Counted
8B7 33459 3.53% 170
8C13 11270 2.32% 905
8E7 3345 0.361% 1663
8F1 32636 0.330% 1515
8F5 22594 0.101% 6941
8F9 30733 0.00% 1880
9A1 32591 0.255% 3532
9A2 18206 0.247% 4866
9A3 32651 0.456% 4825
9A5 18146 0.574% 3658
9B1 21869 0.949% 1791
9B5 15492 0.730% 137
Table 2.2: Fine P-Element map- A fine P-element map was performed using fly
lines with P-elements equally spaced between the region found from the rough
map, cytologic region 8A and 10E. A lower percent white the eyes indicates the p-
element is closer to the mutated gene. A region was identified between 8E7 (0.36%
white eyes) and 9A1 (0.26% white eyes) with a hotspot at 8F9. The fine mapping
only has one hotspot indicating there are not two closely separated regions that
have a lethal mutation. The most likely region for the mutation is around 8F9.
Since Nej is known to interact with Smad proteins, it appeared to be the
most likely candidate and the corresponding region was sequenced from mvent1
mutant larva. The nej gene contains 13 exons and the mRNA is 15729 bases long,
with the mature transcript containing 3276 amino acids. This is longer than the
mammalian CBP protein which contains 2414 amino acids. All thirteen exons
were sequenced, and eleven of twelve introns were fully sequenced. Intron six was
quite large and only the first two hundred base pairs on each side were sequenced.
Five changes were found in nej exons and four changes were found in the introns
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(Table 2.3). The changes in the introns were not in the splicing donor or acceptor
sites and are less likely to affect Nej activity. In the exons, four of the changes
were fairly conservative. However one C to T transition leads to a change of
Glutamine 2844 at base 8527 to a stop codon in exon 12. This change was found
in 2 overlapping high quality sequencing reads. Thus, Nej was pursued as the
most likely candidate for encoding the mvent1 gene.
50
Location Base Change Amino Acid Change
Base 1129, Exon 4 A->T T->S
Base 1198, Exon 4 C->G P->A
Base 1236, Exon 4 Insert CAG Add Q
Base 1260, Exon 4 Deletion Delete Q
Bases 11976:11978, Intron 4 CAA->AGG No changes
Base 12009, Intron 4 Delete T No changes
Base 16248, Intron 10 A->T No changes
Base 8527, Exon 12 C->T Q->stop
Bases 18386, Intron 12 A->G No changes
Table 2.3: Sequencing of nejire- The gene nej was sequenced as the most likely
candidate for containing the lethal mutation. All thirteen exons were sequenced
and all introns were sequenced with at least 200 base pairs on each end. Four
conservative changes were found in the exons and one stop codon in exon 12.
Four changes were found in the introns, but none of the changes were in splicing
donor or acceptor sites. The premature stop codon is the most likely change for
causing the lethal mutant phenotype.
To confirm that the premature stop codon in nejmvent1 caused the mutant
phenotype, non-complementation and rescue experiments were performed. The
nejmvent1 allele showed non-complementation with the nejQ7 allele (Table 2.4). In
addition, the nejmvent1 allele was recused using the balancer for the nejQ7 allele
(Table 2.4). However, the nejmvent1 allele did not show rescue with stock 29782
Dp(1;Y)BSC58 in the Bloomington duplication collection, which is supposed to
contain nej. The rescue and non-complementation data confirm that the affected
gene causing the lethal phenotype is from the stop codon found in nej.
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Cross Number Number bar Number Number bar
non-bar eyed males non-bar eyed females
eyed males eyed females
Line 82, Cross 1 47 21 0 49
Line 82, Cross 2 41 16 0 73
Line 82, Cross 3 19 19 0 35
Line 82, Cross 4 13 13 0 19
Total 120 69 0 176
Line 54, Cross 1 17 32 0 42
Line 54, Cross 2 13 13 0 19
Line 54, Cross 3 6 8 0 14
Line 54, Cross 4 10 7 0 17
Total 46 60 0 92
Table 2.4: nej Non-Complementation and Rescue Data- Two separate fly lines
containing the Mvent1 mutated allele (82 and 54) were crossed to nejQ7 allele that
was balanced over a duplication of nej. The duplication of nej rescued the lethal
male phenotype as 120/189 males and 46/106 males were non-bar eyed for fly line
82 and 54 respectively. The nejmvent1 allele also showed non-complementation
with the nejQ7 allele as no females that were non-bar eyed were found for either
the 82 or 54 crosses. Similar data was obtained in multiple crosses for each fly
line. The non-complementation and rescue data confirm that the mvent1 lethal
mutation is within the nej gene and is now referred to as nejmvent1
Maternal Nejire D/V Patterning Phenotype
I next analyzed the pMad phenotype for maternal nejmvent1 clones. The maternal
nejmvent1 clones have a highly variable phenotype. In pre-cephalic furrow embryos,
all maternal nejmvent1 clones (10/10) had areas with no pMad staining in the
central region along the A/P axis, which is never seen in control embryos (Figure
2.3 A, D, and G). However the severity in terms of how much pMad was missing
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along the A/P axis ranged from a small region (Figure 2.3 D) to most of the
A/P axis (Figure 2.3 G). pMad was always present in the anterior region of the
embryo. In slightly older embryos, just after the cephalic furrow formed, the pMad
phenotype for maternal nejmvent1 clones ranged from relatively normal in 12/27
embryos (Figure 2.3 E) to areas with absent pMad staining in the central region of
the A/P axis in 15/27 embryos (Figure 2.3 H). During germ band extension, 7/15
embryos were relatively normal (Figure 2.3 F) and 8/15 embryos had significantly
expanded pMad expression over the dorsal surface (Figure 2.3 I) compared to
control embryos (Figure 2.3 C). Maternal Nej appears to be required for consistent
pMad patterning on the dorsal surface, and its loss lead to a highly variable
phenotype that is stage dependent.
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Figure 2.3: Nejire Maternal Clones- A-C are His-GFP control embryos and D-I are
maternal nejmvent1 embryo clones. A, D, and G are pre-cephalic furrow embryo. B-
C, E-F, and H-I are post-cephalic furrow embryos. C, F, and I are embryos starting
germband extension. All embryos are oriented with the anterior region on the left
and posterior region on the right. D-F are maternal nejmvent1 embryo clones
that are more similar to control embryos. In pre-cephalic furrow embryos, 10/10
maternal nejmvent1 embryo clones only had regions of absent pMad staining in the
central (D and G) and sometimes posterior (G) region of the A/P axis surface. In
embryos right after the cephalic furrow formed maternal nejmvent1 clones showed a
range from normal (E), 12/27 embryos, to embryos missing pMad staining in the
central region of the A/P axis (H), 15/27 embryos. During germband extension,
8/15 embryos had expanded pMad signaling over the dorsal surface (F) and 7/15
embryos were fairly normal (I).
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2.2.2 Cv-2 Characterization
Crossveinless-2 (Cv-2) is a membrane associated protein that has been shown to
modulate BMP signaling in the wing disk. However, the Cv-2 phenotype has not
been characterized in the early embryo. Here I show the Cv-2 is BMP responsive,
inhibits overall BMP signaling, and leads to a smaller amnioserosa during dorsal
surface patterning.
Cv-2 Expression Patterns
To identify Cv-2s role in embryonic patterning, I first performed in situ hybridiza-
tions for cv-2 mRNA on yw, Cv-21−/−, a mixture of Dpp+/+ or Dpp+/−, and
Dpp−/− embryos (Figure 2.4). In control embryos, cv-2 mRNA first accumulates
broadly over the central region of the dorsal surface, but is absent from the poles
(Figure 2.4 A and C). At the beginning of gastrulation, the cv-2 mRNA is seen
in a graded pattern with more mRNA along the dorsal midline and absent at the
poles (Figure 2.4 D and F). In Dpp−/− embryos, cv-2 mRNA is absent (Figure
2.4). In the Cv-21−/− point mutant, the mRNA is present and follows the same
pattern as control embryos (Figure 2.4 B and E). However this is not surprising
as the Cv-21−/− embryo are protein missense functional nulls, so the mRNA is
still produced but the mature protein is not active. Based on this evidence I con-
clude that Cv-2 is positively regulated by BMP signaling during dorsal surface
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patterning.
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Figure 2.4: Cv-2 In Situ Hybridizations- Cv-2 in situ hybridizations for Yw (A
and D), Cv-21−/− (B and E), Dpp+/+ or Dpp+/− (C and F), and Dpp−/− (G)
embryos. Early pre-gastrulation embryos (A-C) show Dpp to be at low levels
across the central region of the dorsal surface and absent at the poles. In later
gastrulating embryos (D-G) in control embryos (D and F) cv-2 mRNA is expressed
across the dorsal surface, but is more concentrated along the dorsal midline. cv-2
mRNA is absent in Dpp−/− embryos. In Cv-2−/− embryos, cv-2 mRNA follows
the same pattern as control embryos.
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Cv-2 is an Inhibitor of BMP Signaling During DV Patterning
I next investigated how the pMad profiles on the dorsal surface evolve over time
in control and Cv-21−/− embryos. Both Cv-21−/− and control embryos undergo
contraction and intensification of pMad on the dorsal surface (Figure 2.5, 2.6).
pMad starts broadly distributed over about 18 nuclei. Over time the low intensity
signaling contracts by about 5 nuclei, while there is little contraction seen in the
region of high signaling. In the region of high signaling, the peak intensity in-
creases over time. Simple visual inspection between control and Cv21−/− embryos
suggests a difference in the width of pMad between the embryos. However it is not
clear if this difference is significant indicating a need for more precise measure-
ments. Since Cv-21−/− embryos show contraction and intensification similar to
control embryos, without precise quantification between Cv-21−/− and wild type
embryos it is difficult to determine if Cv-2 plays a role in dorsal surface patterning.
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Figure 2.5: pMad Staining on the Dorsal Surface of Cv-21−/− and His-GFP Con-
trol Embryos- A and B show pre-cephalic furrow embryos and C and D show
embryos after the cephalic furrow is formed. A and C are His-GFP control em-
bryos and B and D are Cv-21−/− embryos. The pMad staining starts broad but
contracts and intensifies along the dorsal midline for both control and Cv-21−/−
embryos.
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Figure 2.6: Evolution of pMad in Control and Cv-21−/− Embryos- A-C are His-
GFP control embryos and D-F are Cv-21−/− embryos. Blue lines are post-cephalic
furrow embryos and the purple lines are pre-cephalic furrow embryos. Red dots
are areas of significant difference (p<0.05) between pre- and post-cephalic furrow
embryos. A and D are profiles across the dorsal surface at the midline of the
embryo. B and E are A/P profiles at the threshold T=0.1 and C and F are A/P
profiles at T=0.4. The Dorsal profiles show the peak intensity increase on the
dorsal midline for both Cv-21−/− and control embryos. There is a contraction of
the low intensity signaling (B and E), but the higher intensity signaling does not
show any contraction.
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The pMad phenotype for cv-2 is very subtle, and when I used a standard
antibody staining protocol, I found significant variability in the quality of staining
between samples each day and between days. However, the variability of staining
quality between embryos within each sample was low. When I did not normalize
for the inter-tube staining variability, half the data sets showed the width of Cv-
21−/−pMad staining compared to control embryos was larger and the other half
showed it was smaller. Therefore, I tested four different protocols to find one
that was able to give consistent results. I initially tried three different methods;
the staining method, ratio method, and parallel method, briefly described below,
that did not work to adequately control for staining variability. However, the
fourth procedure, which I refer to as the mixing method, which was developed by
Shavartsman and colleagues (personal communication) was used successfully.
The first method I used involved pre-staining control embryos with a marker
and then mixing them with experimental embryos followed by pMad antibody
staining. yw embryos were collected and split in half. Half of the embryos were
stained with DAPI or Propidium iodide (PI) for 15 minutes, and the other half
were washed in PBT. Then, the embryos were mixed and a standard antibody
staining protocol for pMad was followed. DAPI and PI both diffused out of the
pre-stained embryos and resulted in staining all the embryos. There was a gradient
of intensity of staining, but the difference was not great enough to definitively
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separate the control from the test embryos. Since the binding affinity of DAPI or
PI does not appear to be high enough to prevent bleeding into test embryos, I did
not pursue this method further.
The next method I used was designed to normalize for day to day staining
variations by taking the ratio of the fluorescence intensity (FI) of pMad to RNA
polymerase (pol). While the FI varied from day to day, I tried taking the average
intensity of pMad in the embryo and compare it to the average amount of pol as
an internal control. The average FI of the maximum intensity projection of the
embryo was found by drawing a mask around the embryo. The average embryo FI
of pMad between four different days varied from 32 to 43 and was significantly dif-
ferent (p<0.05) (Table 2.5). However the ratio of pMad:pol did not attenuate the
differences and if anything amplified the day to day variability. The ratios varied
from 0.47 to 0.68 and were significantly different (p<0.05) (Table 2.5). Based on
this data, I concluded that taking the ratio of pMad:pol does not attenuate the
variations in staining between test samples.
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Sample pMad pMad:pol
Sample 1 (N=13) Avg. FI 32.8 0.68
Sample 2 (N=9) Avg. FI 43.0 0.47
Sample 3 (N=22) Avg. FI 37.3 0.52
Sample 4 (N=15) Avg. FI 33.9 0.62
Anova p-Value 9.0 ∗ 10−4 6.2 ∗ 10−14
Table 2.5: Ratio Method for Normalizing Antibody Staining Between Samples-
The average FI of pMad and pol was found for each embryo and the ratio of
pMad:pol was found to see if it could attenuate the day to day variability in
staining. Four samples were looked at with the number of embryos (N) ranging
from 9-22 per sample. An ANOVA p-value comparing the four different days found
significant differences for both pMad and pMad:pol. The ratio method made the
differences between the four samples worse and does not work the control for day
to day variability.
Next I attempted to control for differences due to the fixation process and
antibody staining by collecting and staining yw and Cv-21−/− embryos in parallel.
First, the embryos were fixed in parallel to minimize the differences due to the
fixation process. Next the embryos were stained in a chamber that allowed fluid to
move between the different chambers, so that both the control and test embryos
were exposed to the same wash and antibody solutions. The yw and Cv-21−/−
embryo collections were each split in half and all 4 sets were fixed in parallel and
stained in the chamber allowing exposure to the same solutions. This process
was repeated two times. There was no significant difference between the samples
within the same genotype (Table 2.6). However, the two sets of data showed
opposite results for the difference between yw and Cv-21−/− in the average FI.
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This indicates that fixing in parallel is not sufficient to obtain reproducible results
for the average FI between samples. When the width of the pMad positive nuclei
along the A/P axis was examined for the embryos fixed together and split in half
for antibody staining, there were areas of significant difference in both sets of data
(Figure 2.7). While staining embryos in the same chamber reduced the variability
in the width of pMad positive nuclei, there are still subtle differences.
Samples pValue
Yw set 1 a vs b 0.15
Cv-2−/− set 1 a vs b 0.30
Yw set 2 a vs b 0.72
Cv-2−/− set 2 a vs b 0.43
Table 2.6: Average Fluorescence Intensity for Embryos Processed Using the Par-
allel Method- On two separate days yw and Cv-21−/− embryos were split in half,
fixed in parallel, and stained in the same chamber. The table shows the average
FI for each set of data that were processed in parallel. The average FI between the
samples did not show any differences for fixing in parallel and staining together.
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Figure 2.7: Parallel Method for Embryo Processing- On two separate days yw
and cv-2 1−/− embryos were split in half, fixed in parallel, and stained in the same
chamber. A) Width of pMad positive cells at the relative position across the A/P
axis for yw embryos from set 1. Blue is yw set 1a, green is yw set 1b, and red
are areas of significant difference. B) Width of pMad positive cells at the relative
position across the A/P axis for cv-2 1−/− embryos from set 2. Blue is cv-2 set 1a,
green is cv-2 set 1b, and red are areas of significant difference. While the average
FI is not different between the samples, there are areas of difference along the A/P
axis in comparing the width of the number of cells. Thus, there are still sample to
sample variations that cannot be corrected by simply fixing and staining embryos
using the same solutions.
The mixing method is the only method where all embryos are exposed to the
same environmental variables throughout the entire process. Thus, this proved
to be the most reliable method for examining subtle changes in pMad signaling
profiles. In this method, control and mutant embryos are collected separately,
mixed together, and then fixed and stained in the same tube from the beginning of
the procedure. To distinguish control (wt) embryos from mutants, a GFP reporter
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is incorporated into the wt control parents that enables the investigator to sort wt
embryos from mutant on the basis of GFP fluorescence. This method was the only
one in which consistent results for differences in the pattern and pMad staining
intensity was observed between Cv-21−/− mutant and control (Histone-GFP+
(His-GFP)) embryos. However for each batch processed, there was a difference in
the average width of the pMad positive nuclei, which depended upon the intensity
of the staining. However the pertinent different between the control and mutants
remained the same. Thus by mixing His-GFP embryos as a control with Cv-21−/−
embryos I were able to get consistent results in the difference in width of signaling
between the two samples.
I first studied the difference in pMad profiles in His-GFP control and Cv-
21−/− embryos raised at 25◦C. Cv-2−/− embryos have a higher average FI and a
wider number of total pMad positive nuclei compared to His-GFP control embryos.
Both genotypes follow similar pMad profiles along the D/V axis with the pMad FI
initially slowly increasing and then more rapidly increasing closer to the Dorsal
midline (Figure 2.8 A-C). Along the A/P axis, the pMad intensity is lowest in
the anterior region and highest in the posterior region. In the lateral region
of the dorsal surface where pMad intensity is low, both Cv-21−/− and His-GFP
embryos have similar pMad expression profiles. On average, the width of the
pMad stripe along the dorsal midline, at four different thresholds in the central
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region of the embryo, for Cv-21−/− mutant embryos is about 2 nuclei more than
for a comparably aged His-GFP+ wt embryo (Figure 2.8). Cv-21−/− embryos
also have a higher peak FI (Figure 2.8). The width of pMad expression at the
poles of the embryo is not affected by Cv-2. I also examined if the Cv-2 mutant
phenotype varies depending on temperature. However, the differences in pMad
profiles between mutant and control is the same pattern at 18◦, 21◦, and 25◦C
(Figure 2.9). At all temperatures the width of the pMad stripe in Cv-2 mutant
embryos is 2 nuclei wider than His-GFP+ controls. Thus, I conclude that Cv-2 is
a negative regulator of BMP signaling during dorsal surface patterning.
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A B 
C D 
Figure 2.8: pMad Profiles at 25◦C Comparing Cv-21−/− (blue) and His-GFP
(green)Control Embryos- A-C shows p-Mad profiles along the D-V axis with A
being an anterior slice, B a central slice and C and posterior slice. At all positions
along the D-V axis the Cv-2 embryos have a higher and wider p-Mad staining. D)
Cv-21−/− embryos (blue lines) are 2 nuclei wider than His-GFP control embryos
(green). Red dots show where there is a significant difference from the dark blue
line (p<0.05) using a students t-test. Threshold (T) taken at T=0.4.
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A) 18°C B) 21°C 
C) 25°C D) 25°C 
Figure 2.9: pMad Profiles Along the AP axis for Cv-21−/− (blue) and His-GFP
(green) Control Embryos at 18-25◦C- A is at 18◦C, B is at 21◦C, C is at 25◦C and
D is at 25◦C. All profiles show a 2 nuclei difference in width. There is a difference
in the width of the p-Mad between samples which is most likely differences in the
intensity of p-Mad staining. Red dots show where there is a significant difference
from the dark blue line (p<0.05) using a students t-test. Threshold (T) taken at
T=0.4
Cv-2 May Increase the Noise in the Width of pMad Positive Nuclei
During D/V Patterning
Since Cv-2 has been proposed to reduce the noise caused by putatively low levels
of Dpp in the PV space [71], I examined the average variability in the width of the
pMad stripe in Cv-21−/− embryos (Figure 2.10). To study the noise or variability
in the width of pMad positive nuclei, I used the coefficient of variation (CV) to
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measure noise levels. The coefficient of variation is the standard deviation/mean
for a data set. Since the CV is computed for each data set, I was unable to
obtain meaningful statistics due to not having enough replicates to determine
if there is a statistical difference for the CV between His-GFP control and Cv-
21−/− embryos. However, there is a trend for Cv-21−/− embryos to have a lower
CV than His-GFP control embryos (Figure 2.10). Unlike the prediction of one
current mathematical model where Cv-2 buffers noise created by fluctuations in
Dpp levels, Cv-2 may actually increase the amount of noise in Dpp signaling
during dorsal surface patterning.
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A) 18°C B) 21°C 
C) 25°C D) 25°C 
Figure 2.10: Coefficient of Variation for Width on the Dorsal Surface at 18-25◦C
Comparing Cv-21−/− (blue) and His-GFP (green) Control Embryos- The coeffi-
cient of variation of the width of pMad positive nuclei at T=0.4 was plotted along
the A/P axis for Cv-21−/− (blue) and His-GFP (green) embryos at 18◦C (A), 21C
(B) and 25◦C (C and D). At approximately 75% of the total positions along the
A/P axis, Cv-2 mutants have a lower CV than control embryos.
Loss of Cv-2 Leads to a Larger Amnioserosa
The pMad positive nuclei posterior to the cephalic furrow ultimately will form
amnioserosa cells. To determine if the 20-30% change in the width of the pMad
nuclei ultimately affects cell fate and tissue size, later in development, the average
number of amnioserosa cells was determined at the germband retraction stage by
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counting the number of hindsight, a marker for the amnioserosa, positive cells
(Figure 2.11). There is a 35% increase in the size of the amnioserosa of Cv-
21−/− embryos (p = 2.05 ∗ 10−15) compared to the His-GFP+ controls. Thus, the
change in early Dpp signal reception in Cv-21−/− mutant embryos has a functional
consequence during development since in translates into a significant change in
the final size of the amnioserosa.
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Figure 2.11: Size of the Amnioserosa in Cv-21−/− and His-GFP Control Embryos-
The amnioserosa of Cv-21−/− (A) and His-GFP (B) embryos is shown in red. Blue
shows the nuclei with DAPI staining. C) There is an average of 232 amnioserosa
cells for Cv-21−/− embryos and 172 amnioserosa cells for His-GFP embryos with
a p-value of 2.05 ∗ 10−15.
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2.3 Discussion
I have studied two genes that are involved in the feedback control and robustness
of Dpp signaling during dorsal surface patterning in the early Drosophila embryo.
I have identified a new novel allele of nej with a stop codon near the C-terminus.
This truncation leads to a highly variable Dpp patterning in the early Drosophila
embryos. I have also studied the function of Cv-2 during dorsal surface patterning.
Cv-2 is a BMP response gene that inhibits BMP signaling during dorsal surface
patterning. Cv-21−/− embryos have a slightly larger area of pMad signaling that
leads to a larger amnioserosa. Surprisingly, I found that Cv-2 has no effect or
may actually decrease the robustness of Dpp signaling. Thus I have identified one
protein, Nej, that enhances the robustness of Dpp signaling and another protein,
Cv-2, that appears to reduce robustness with respect to wild type.
2.3.1 The Role of Nej in the Robustness of Dorsal Surface
Patterning
We have identified a new allele of nej with a stop codon in the 12th exon that is
most likely causes a dominant negative phenotype (see below). Curiously, I was
unable to map the mutation using the Bloomington stock collection duplication
series. The end points of the duplications in the Bloomington collection have
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not all been confirmed, so it may be that nej was not actually contained in any
of the duplications that I used. Another possibility is that while nej coding
sequences might be contained on the Bloomington duplications, some regulatory
areas may be missing. In either case, the fact that the Dp(1;Y)FF1 duplication
derived from the nejQ7 containing stock did successfully rescue the mvent1 lethal
phenotype helped confirm that mvent1 was near the nej locus. We were able to
further fine map the mvent1 mutation using a P-element recombination strategy
and then confirmed that mvent1 is a nej allele by sequencing. This allele has
a premature stop codon located near the C-terminus of the gene at the 2844th
amino acid out of 3246 amino acids. This truncation removes a glutamine and
alanine rich domain of Nej [103, 104, 105]. A deletion of Nej starting at amino
acid 2677 produces a dominant negative mutation when assayed for activity in
the Drosophila eye. Thus it is likely our mutation is also a dominant negative
mutation. The glutamine and alanine rich region is most likely important for the
activation of transcription [105]. The mammalian homologue of Nej, the CREB
Binding Protein (CBP), is significantly shorter than Drosophila Nej, however, it
too contains a glutamine rich domain [80], likely indicating conserved function for
this portion of the protein in transcriptional regulation. Since the nejmvent1 allele
does not truncate the entire glutamine rich domain, it is possible that it does
not completely inhibit transcriptional activation and represents a hypomorphic
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mutation. However, a dominant negative phenotype for nejmvent1 allele might
also arise if the truncated protein is able to assemble into complexes with other
transcriptional binding partners but is unable to initiate transcription. Additional
genetic tests will be required to determine if nejmvent1 is a dominant negative or
hypomorphic mutation.
The nejmvent1 allele most likely inhibits dorsal surface patterning through phys-
ical interactions with Mad. Previous work has shown that Nej residues 2240-2608
[80] bind to the MH2 region of Mad and loss of nej affect Dpp signaling in many
tissues including the midgut [80], trachea [80, 106], and wing disc [80]. Evidence
from the wing disc suggests that Nej functions downstream of the Dpp receptor
Saxophone [80]. Previous work has also suggested a role for Nej in regulating
D/V patterning. The hypomorphic nej 1 allele leads to loss of dorsal structures
and diminished Dpp target gene expression patterns with in the dorsal ectoderm,
but the neurogenic ectoderm appears intact [39]. The loss of high levels of Dpp
signaling in nej 1 mutants is thought to result from the decrease in expression
levels of scw, tsg, and tld [81] thereby prevent the Dpp gradient from forming
correctly along the dorsal midline. In the early embryo the Nej acetyltransferase
activity is not required for Dpp patterning [107]. It is presumed that Nej acts as
a bridge between the transcription factor Mad and the transcriptional machinery
[107]. Thus the nejmvent1 phenotype is most likely due to Nej binding to Mad
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and occupying various transcriptional start sites of Dpp target genes, but being
unable to properly interact with other components to initiate transcription. It is
also likely the nejmvent1 allele affects other transcriptional activities besides those
involving pMad. For example, in the early embryo nej is uniformly expressed
[108] and also interacts with Deformed to mediate ventral surface specification
[79] and Bicoid to mediate anterior-posterior patterning [109]. Additional stain-
ing of nejmvent1 mutant embryos with markers for other patterning processes will
be required to address this issue.
Although nej has been previously implicated in mediating dorsal surface pat-
terning, it is hard to directly compare my results with the previously reported data
since the embryos where mounted very differently. I found loss of pMad in the
central and often posterior regions of the A/P axis of nejmvent1 whereas in nej 1 mu-
tant embryos, pMad was seen in the anterior most cells, but not in posterior cells
[?]. Thus nejmvent1 may be weaker than the nej 1 allele during early Dpp embryo
patterning, however I observed a stronger phenotype in the post-cephalic furrow
embryos compared to the nej 1 allele. At cellularization, nej 1 mutant embryos
were reported to have recovered normal pMad staining presumably in both males
and female embryos. The nejmvent1 allele only showed recovery in approximately
50% of the embryos. In the other 50% of the embryos I observed significantly
expanded pMad expression on the dorsal surface. While in our crosses we were
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unable to differentiate between males and females, the 50/50 split suggests we
may have a male / female difference. One possibility is the zygotic expression
of Nej from the paternally supplied balancer chromosome rescues female pMad
patterning, whereas in males that lack the X chromosome balancer, no zygotic
expression of wt nej is possible leading to loss of dorsal structures that require
high levels of BMP signaling. The eventual broad pMad staining detected at gas-
trulation likely reflects the second wave of BMP signaling that occurs in dorsal
neuroectoderm as gastrulation progresses [44].
One intriguing possibility concerning the role for Nej is that it may help achieve
robustness in early Dpp patterning. My data showed a range of severity in the
abnormal pMad staining at all stages. As described, however, this variability
might simply reflect hypomorphic activity for this nej allele. It is interesting to
note that a range of phenotypes was also produced by the nej 1 allele during midgut
formation [78]. To truly determine if Nej contributes to robustness of early D/V
patterning it will be necessary to analyze the phenotype of a true molecular null
such as a complete deletion of the gene or a very early stop codon.
In conclusion, I have found a new allele of nej that truncates the glutamine
rich domain at the C terminal end of the protein. Based on comparing our allele
to other published nej alleles, nejmvent1 is either hypomorphic or a dominant
negative allele either of which could explain the variable loss of dorsal patterning
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through effects on Dpp signaling or the ability of pMad to properly regulate Dpp
target gene transcription.
2.3.2 The Role of Cv-2 in Dorsal Surface Patterning
I have shown that cv-2 is a BMP responsive gene that is a negative regulator
of BMP signaling in dorsal surface patterning. I found that cv-2 mRNA is com-
pletely absent in Dpp null embryos, indicating BMP expression is required for cv-2
expression. The pattern of cv-2 mRNA expression follows that of BMP signaling
on the dorsal surface where BMP signaling starts broad but contracts and inten-
sifies to a narrow region along the dorsal surface. Induction of cv-2 expression in
response to high BMP signaling is consistent with results in the wing disc [57] and
with results on vertebrate cv-2 homologs [97, 96, 98]. Since the cv-2 null allele is
a point mutation in the gene that renders the protein inactive, it is not surprising
that mRNA expression for the cv-2 null allele was similar to that of controls, and
in fact may have slightly higher amounts of mRNA than controls since I also found
that the level of BMP signaling was increased in cv-2 1−/− embryos. Thus similar
to results in the wing disc and vertebrate models, cv-2 expression requires BMP
signaling.
In order to consistently and accurately characterize the cv-2 1−/− phenotype
with respect to BMP signaling, very careful controls were needed. We found that it
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was necessary to control for all steps in the fixing and antibody staining protocols
in order to get consistent results. In particular, the anti-pMad antibody seemed to
be very sensitive to the fixation process, and without identical fixing conditions
consistent results were not obtained. I was not able to get consistent results
processing embryos in parallel or by staining with the same antibody solutions as
has been proposed for quantitative image analysis by other groups [110, 111, 112,
113, 114]. Before identifying a staining method that yielded consistent results,
my data initially showed that the cv-2 1−/− phenotype was more pronounced at
lower temperatures. However, I found this to be false when both fixation and
antibody staining was carried out in the same tube using a mixture of control and
mutant embryos. Thus it is very important to have identical embryo processing
conditions when quantitating antibody staining. My results showed that the width
of the signal varied greatly from 8-16 nuclei depending on the intensity of the
staining and the threshold examined. My results indicate that quantification
from fluorescence intensity must be done in a relative manner between carefully
controlled samples as the results depend greatly upon the quality of the antibody
staining.
Our results showed that both control (His-GFP) and cv-2 1−/− undergo con-
traction and intensification of BMP signaling. On the dorsal surface, peak signal-
ing intensifies over time and the low level signaling contracts towards the midline.
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The amount of contraction that occurs over time depends upon the threshold of
signaling intensity examined. For low levels of signaling we found a contraction
of 5 nuclei, which is consistent with previous results [44, 40]. However, our data
may actually underestimate the total amount of contraction occurring as we could
not precisely stage early embryos. As a result I grouped together all data from
the early time point when the contraction is proposed to be happening. For high
level of signaling, we did not see any contraction, but we did see an increase in
the peak intensity of the strong signaling. The inability to see any contraction in
the high signaling area may be due to how we grouped the pre-cephalic furrow
embryos together. Some embryos in the pre-cephalic furrow data set had already
undergone a significant amount of contraction and intensification, which may have
skewed the data towards intensification of pMad along the dorsal midline. Since
both cv-2 1−/− do undergo some contraction of pMad signal intensity, Cv-2 is not
likely the sole mediator of this event.
While in cv-2 mutant embryos contraction of pMad does occur, the amount of
pMad contraction is less than wild type. There was a 2 nuclei change in the overall
width of BMP signaling. While only 2 nuclei may seem like a subtle change, it
corresponds to a 20-30% increase in the width of the pMad stripe depending upon
where the threshold for high level signaling is drawn. The 2 nuclei change is also
significant as it leads to a 35% increase in the size of the amnioserosa, which is
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specified by high levels of BMP signaling. Thus Cv-2 is necessary for the full
contraction of Dpp/Scw on the dorsal midline and is required for correct sizing of
the amnioserosa.
It has been proposed that in order for both contraction and intensification of
BMP signaling during dorsal surface pattering to occur, a positive feedback mech-
anism is needed [22, 52]. Cv-2 has been hypothesized to be involved in positive
feedback to up-regulate BMP signaling. However, I have shown that Cv-2 func-
tions to slightly narrow BMP signaling through a negative feedback mechanism.
My data shows Cv-2 contributes to the contraction on BMP signaling through
shifting the BMP profile downwards which both lowers peak signal intensity and
narrows the overall signaling width. However, in cv-2 mutant embryos some con-
traction and intensification of pMad signal intensity still occurs. Thus there still
must be unknown factors that contribute to the contraction and intensification
of pMad. Several ideas have been suggested including an inhibitor in the lateral
regions of the dorsal surface [22], modulation of Dpp/Scw endocytosis rates [111],
or modulation of receptor activity or levels [111, 22]. Mathematical modeling
suggests that an up-regulation by a positive feedback mechanism best fits the
experimental data [111]. However, there is currently no experimental evidence or
new protein candidates that would favor one of these hypotheses over another.
Thus, it is still an open question on how Dpp/Scw signaling both contracts and
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intensifies along the dorsal surface.
Cv-2 being a negative regulator of BMP signaling is also consistent with previ-
ous modeling results. Using binding parameters derived for BMP-2, the vertebrate
homologue of Dpp, interactions with to BMP receptor IA and to vertebrate Cv-2
and then performing a parameter scan employing different rates for BMP transfer
between Cv-2 and the BMP type IA receptor, one model found that Cv-2 acted
as a strong antagonist of BMP signaling over 75.5% of the parameter space [57].
In cell culture experiments, the effects of Cv-2 on Dpp were also found to be
purely antagonistic [57]. These results are also consistent with studies employing
human Cv-2 where it has been shown to be an antagonist of BMP-2 and -4, during
osteoblast and chondrocyte differentiation [96].
The BMP inhibitory role of Cv-2 in Dorsal surface patterning is different from
the role of Cv-2 in modulating BMP signaling in the wing disc. In this tissue,
Cv-2 has a biphasic role where low levels of Cv-2 enhance BMP signaling and
high levels of Cv-2 inhibit signaling [57, 76]. However, in this case Cv-2 likely
interacts with both Dpp and the BMP ligand Glass Bottom Boat (Gbb) for proper
crossvein patterning. Gbb has low affinity for the BMP receptor and modeling
indicates it can produce multiple steady states of BMP activity with a larger
parameter set than for Cv-2 interacting with Dpp alone [57]. In the chick, Cv-2
has been shown to enhance BMP-4 signaling, [98, 97]. Thus, it appears that in
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certain circumstances Cv-2 enhances BMP signaling while in others it may act
strictly negatively depending on the various binding partners involved. While
our data shows that ultimately Cv-2 inhibits Dpp signaling during dorsal surface
patterning, it is possible that it may transiently enhance Dpp signaling during the
earliest stages, but then as its concentration rises it switches to a pure inhibition
mode. My analysis only looked at the effect at the endpoint of the contraction
process when Cv-2 levels would be the maximum, so it is possible that I may have
missed a very transient time point during the earliest stages of Dpp signaling
where Cv-2acts as a BMP agonist.
My data further suggests that Cv-2 either has no effect on robustness of Dpp
signal or may actually make the output less robust. This conclusion is opposite
from what some mathematical models predicted which is that Cv-2 should reduce
noise the system [71]. The mathematical model assumed that Cv-2 was a positive
regulator of BMP signaling as seen in the wing disc, but I found that this is not
the case during dorsal surface patterning and that it actually a negative regulator.
Thus, Cv-2 may buffer noise when it is a positive regulator and enhance noise
when it is a negative regulator of signaling. If there are fluctuations in embryonic
BMP signaling the negative regulation may enhance these fluctuations leading to
a higher level of noise in signaling. It is not apparent how increased noise in BMP
signaling might be advantageous for embryonic development.
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In summary, I found that Cv-2 is a negative regulator of BMP signaling during
dorsal surface patterning. In its absence, signal contraction about the midline still
occurs but the peak levels of BMP signaling on the dorsal surface are increase by
20-30% leading to a large amnioserosa. The fact that contraction still occurs in
the absence of CV-2 suggest that there must still be other unidentified factors
that are involved in controlling the dynamics of BMP signal output on the dorsal
surface.
2.4 Conclusion
I have studied two proteins that are involved regulation of BMP signaling. We
have identified a new allele of nej that has a stop codon in the 12th exon on the
gene. Loss of nej leads to a high degree of variation in BMP signaling output in
the embryo. I also studied the role of Cv-2 in the feedback regulation of BMP
signaling. Cv-2 is found to be a BMP response gene that acts as a negative
feedback regulator of early embryonic BMP signaling. This inhibition leads to a
smaller peak number of pMad positive nuclei on the dorsal surface and possibly
to a slight loss of robustness in the average width of pMad expression domain.
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2.5 Experimental Methods
2.5.1 Nejire Mapping
The Mvent1 mutant was a gift from Armen Manoukian, Univeristy of Toronto as
a possible fly line with a dorsal surface patterning defect. A stable fly line is kept
as Mvent1 / FM7. As an initial attempt to map Mvent1, I tried using a Dupli-
cation mapping technique employing fly lines with sections of the X chromosome
duplicated on the 3rd (DC duplication series) or Y (DC duplication series) chro-
mosome from Bloomington Stock Center [101, 102]. If Mvent1 is covered on the
duplicated element, the duplication should rescue lethality. However, for unknown
reasons, I was not able to map Mvent1 using the duplication mapping technique.
As an alternative to duplication mapping I turned to a P-element mapping strat-
egy using stocks in Tables 2.1 and 2.2 from the Bloomington Stock Center. Virgin
Mvent1 females in a w− background were crossed to flies containing a w+ marked
P-element on the X chromosome. Non-FM7 F1 Females containing the Mvent1
chromosome and the P-element chromosome were crossed to F1 progeny males.
F2 progeny males were scored for eye color, with red eyes indicating no recom-
bination and white eyes indicating that recombination occurred. The closer the
mutation is to the P-element the lower the probability of recombination. Approxi-
mately 100-7000 males were scored per fly line. Using this methodology, I mapped
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Mvent1 to within three genes located at (8F2-8F9). Based on the strong maternal
phenotype, I guessed that the Mvent1 mutation might be in nejire, since this is a
known maternally expressed gene [39].
2.5.2 Nejire Sequencing
Genomic mvent1 DNA was extracted for 200 L1-L2 nejire mutant larva. The
larva were ground in 1mL of G buffer (13.7 ML 50% 1.46M sucrose, 10 mL 0.5M
EDTA pH8, 10mL 1M Tris pH9, 2.5mL 20% SDS in 63.8mL H2O). Another 1mL
of G buffer was added and the solution was heated to 70◦C for 20 minutes. The
solution was centrifuged at 5K for 10 minutes. The supernatant was extracted
and 1/2 volume H2O was added. Two phenol extractions were performed fol-
lowed by, a phenol-CHCl3 extraction and then one CHCl3 extraction. The DNA
was precipitated by addition of an equal volume of isopropanol followed by cen-
trifugation at 10K for 10 minutes. The pellet was dried and then resuspended in
35ul of 5M NaCl. This was followed by a phenol extraction (2 times), a phenol-
CHCl3 extraction and a CHCl3 extraction. The aqueous phase was removed after
the final extraction and 2 volumes of 95% ethanol were added and the mix cen-
trifuged at 10K for 10 minutes. The pellet was washed with 70% ethanol, dried,
and resuspended in 100ul H2O.
The nej gene was amplified using PCR in 5 different fragments using the
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primers listed in Table 2.7. A high Fidelity PCR System (Roche) was used for
PCR amplification. The 5ul of PCR product were combined with 2 ul ExoSAP-IT
(Affymetrix) and heated to 37◦C for 15 minutes and 80◦C for 15 minutes. 3.5ul of
the ExoSap solution was combined with 1 ul sequencing primer (Table 2.8) and
7.5ul H2O. The mixture was sent to Genewiz for sequencing. The sequencing data
was analyzed using MacVector. The sequence was compared to the extended gene
region and transcript sequence for nej, and nej-RA from Flybase.
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Name Sequence Direction Pair
nej set1 for t2 CCTCGCCAGCCACGCCTTTT Forward nej set1 rev t2 and nej set1 reverse t2b
nej set1 rev t2 GCCGGCTGAGCGCCTTGAAT Reverse nej set1 for t2 and nej set1 forward t2b
nej set1 forward t2b GGCATGAACACCATTGCGCAGG Forward nej set1 rev t2
nej set2 forward CAAGGACAGCAGGTTGC Forward nej set2 reverse
nej set2 reverse GATGCTCTCCGGCTGTC Reverse nej set2 forward
nej set3 forward GCGAGAATACGAACGGC Forward nej set3 reverse
nej set3 reverse GCCATCGAACATCGAGC Reverse nej set3 forward
nej set4 forward CCATCTCGCTTGCACGC Forward nej set4 reverse
nej set4 reverse GGCTAACTGCCACACCG Reverse nej set4 forward
nej set5 for t2 AACTGCCGCCTGCCATCGTG Forward nej set5 rev t2 and nej set5 forward t2b
nej set5 rev t2 TCCCTGCCGGTTGGTCTTCGT Reverse nej set5 for t2 and nej set5 forward t2b
nej set5 reverse t2b CCTGAGTAGAAACGCCTGGCGAC Reverse nej set5 for t2
Table 2.7: Sequencing Primers for Mvent1 DNA Fragment Amplification- The mvent1 (nej ) gene was broken
into 5 overlapping fragments for DNA Amplification. The primer name, sequence, direction, and primer pair
with are listed in the table.
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name Sequence
nej set1 f1 seq GGATCCAAGTGAGTACCG
nej set1 R1 seq GAGATATCCGCTGGAGG
nej set1 f2 seq CCCAGATGAACGGAGCC
nej set1 f3 seq CTGACCAACAGCGTTGG
nej set1 f4 seq CAACAACTTCTCGCCCAG
nej set1 f5 seq CCTGAATCCGAACAGGG
nej set 1 f6 seq /nej set2 forward CAAGGACAGCAGGTTGC
nej set2 f1 seq GGACCAAATGTTCTGCCG
nej set2 R1 seq GGAATGTTGCCACCCAG
nej set2 f2 seq GGCGACAACGAGAAAGAC
nej set2 f3 seq GGACCACCTGGAATACTG
nej set2 f4 seq CAGGCGACTAGCAACAG
nej set2 f5 seq GGTACACCACTCAGCTC
nej set 2 f6 seq / nej set 3 forward GCGAGAATACGAACGGC
nej set3 f1 seq GAGGATGGACTCGATGG
nej set3 R1 seq GTCACCTGCATTGGGTG
nej set3 f2 seq GGCACTATACGCACCAAC
nej set4 f1 seq CGATACGGTCACACTGG
nej set4 R1 seq GAACACGTAGACGCTTGG
nej set4 f2 seq CTGCGTACTCTGGCTGG
nej set4 f3 seq CAGCTGGGCTACACAATG
nej set4 f4 seq GAAGGGCCAGAAGAAGG
nej set4 f5 seq GCGCTACCACTGTACTG
nej set 4 f6 seq / nej set 5 forward CAAGCAGCAGCAGTCAC
nej set5 f1 seq CGTGGCAGTTCCATCGC
nej set5 R1 seq CCATGCGATACCTGCTG
nej set5 f2 seq CAAGCCCGCTATGCCAAC
nej set5 f3 seq GCAGCAGCAACAGCAAC
nej set5 f4 seq CAACACAGGTGCCCAAC
nej set5 f5 seq GCTCAGGTGATGGGTCC
nej s6 fa2 seq GCGGCGGTAAGGATAAC
nej s6 ra2 seq GTTGGTGCGTATAGTGCC
nej s7 for seq CAGCACATCCTTGCCATACT
nej s7 rev seq GGTTGCTGTTGCTGCTG
nej s6 rev frag seq CCTTAGCACGTCTCGAC
nej s4 r1b GGTTTACTCAGGAGCAAG
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nej s1 r1/s1f1 CCATCTGAGTGCCCACC
nej s2 GGATGTCGATGTGGTGG
leth r1b CTGCAGCTGCTGCAACTG
leth r2b GACGGTGGCTTGGACTC
nej set1 for t2 CCTCGCCAGCCACGCCTTT
nej set1 forward GTCAAAGTGCTAGGCGAC
nej set1 forwardb AATGGCAACAATGGCATGAAC
nej set1 forward t2b GGCATGAACACCATTGCGCAGG
nej set3 forward GCGAGAATACGAACGGC
Table 2.8: Mvent1 Sequencing Primers- The mvent1 gene was sequenced using 45
sequencing primers. The primer name and sequence are included in the table.
2.5.3 Maternal Nejire Clones
Maternal germline clones for the nejmvent1 allele were made by crossing
Mvent1FRT01/FM7-GFP; nosGal4-UASFLP/Cyo-GFP with OvoD FRT101 Bloom-
ington Stock Center line 1813. The F1 progeny were crossed to yw males and the
F2 progeny were collected on apple juice plates as described in section 2.5.5. The
embryos were processed for pMad antibody staining as described in section 2.5.5.
2.5.4 Cv-2 In Situ Hybridizations
Cv-2 in situ hybridizations were performed to study Cv-2 mRNA expression pat-
terns in yw: Dpphinr46−/−; Cv-21−/−, and embryos. Stable homozygous stocks
of the Cv-2KO1 fly line [57] for performing the Cv-2 experiments could not be
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made. Instead I used the Cv-21−/− fly line which by most reports is a strong
loss of function and was obtained as a gift from Seth Blair [115]. DppHinr46 is an
embryonic null allele and was maintained over CyoDpp23. The Dpp null embryos
were identified by their deep cephalic furrow morphology.
Cv-2 mRNA probes were made from cv-2 cDNA in pGem7+, a gift from Seth
Blair. XbaI and HindIII restriction enzymes were used to linearize the cDNA.
Digoxigenin-UTP (digU) labeling of the RNA probes was done using the Ri-
boprobe kit from Promega using the T7 and SP6 polymerases. Embryos were
collected as described in Section 2.5.5 and stored in 100% ethanol. Embryos were
brought into 0.1% PBTween (PBTw) by 5 minute washes in 50/50 ethanol/PBTw,
30/70 ethanol/PBTw, then 100% PBTw. The embryos were fixed for 25 minutes
in PBTw+5% formaldehyde, and then washed 5 times in PBTw. Embryos were
incubated in PBTw+4ug/ml proteinase K (Roche) for 5 minutes. Then, the em-
bryos were washed quickly twice with PBTw, and then four time for 2 minutes
each in PBTw. The embryos were washed for 10 minutes in 50/50 PBTw / embryo
hybridization solution (50% formamide, 5X SSC, 50 ug/ml heparin, 0.1% Tween-
20, and 100 ug/mL salmon sperm DNA in H2O). Then the embryos were washed
in 100% embryo hybridization solution for 2 minutes at room temperature, fol-
lowed by incubation in hybridization solution for 2 hours at 55◦C. The cv-2 probe
was prepared by adding 5ul of digU cv-2 probe to 25ul of hybridization solution
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and heated to 80◦C for 5 minutes, followed by quenching on ice. The probe was
added to the embryos and hybridized at 55◦C for 30 hours. 5 washes were done
over 3 days at 55◦C in embryo hybridization solution. Embryos were brought into
PBTw with four 20 minutes washes in 800/200, 600/400, 400/600, and 200/800
hybridization solution/ PBTw. Embryos were then washed 5 more times over 24
hours in PBTw. Embryos were incubated in pre-absorbed anti-Digoxigenin-AP
Fab fragments (Roche) at 1:2000 overnight at 4◦C. Then embryos were washed
four times in PBTw over 24 hours. Embryos were washed 2 more times for 5 min-
utes in Alkaline phosphatase (AP) staining buffer (100mN NaCl, 50 mM MgCl2,
100 mM Tris pH9.5, 0.1% Tween 20 in H2O). 3.38ul of 100mg/mL of NBT (Roche)
and 3.5ul of 50mg/mL of BCIP were added to 1 mL of AP staining buffer, and the
solution was added to the embryos for 48 hours. Then the embryos were washed
3 times in PBTw and stored in 80% glycerol and 20% PBTw. Embryos were
mounted on slides with the dorsal surface facing up and imaged using a Nikon
Optiphot light microscope at 20X with a Namarksi lens and ProgRes Mac Capture
Pro2.6 software.
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2.5.5 Embryo Collections, Antibody Staining, and Imag-
ing
Cv-21−/− and yw or His-GFP embryos were collected at 18, 21, and 25◦C on ap-
ple juice plates for histochemistry analysis. Flies were allowed to acclimate to the
temperature for at least 48 hours before embryos were collected. The embryos
were devitellinized with bleach for 2 minutes, fixed in 500µL heptane, 500 µL
PBT, and 70 µL electron microscopy grade paraformaldehyde for 20 minutes, and
then dechorionated with 3 washes of methanol. The embryos were exposed to as
little methanol as possible since it decreases the quality of the pMad staining. The
embryos were stored in either ethanol at -20◦0C or PBT at 4◦C. The quality of
the staining did not change for storage in either ethanol or PBT. If the embryos
were stored in ethanol, they were brought back to PBT by 10 minutes washes of
75%, 50%, and 25% ethanol in PBT. Then, the embryos were washed for 10 min-
utes 4 times in PBT, and were incubated overnight at 4◦C in primary antibody.
Antibodies used were Epitomics Phospho Smad3 (pS423/425) Rabbit Monoclonal
antibody (1:500-1:1000) to visualize the amount of pMad, DAPI (1:300) to stain
nuclei, Clontech Mouse monoclonal JL-8 antibody (1:1000) for GFP, and Covance
RNA Polymerase II H5 Mouse Monoclonal antibody (1:1000) for polymerase an-
tibody staining. Then, the embryos were washed 4 times in PBT for 10 minutes,
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incubated in Alexa Flourophore 488 or 555 secondary antibodies for 4 hours at
room temperature, and washed 4 times in PBT for 10 minutes. During the second
to last wash, DAPI at 1:300 was added. The embryos were stored in 80% glycerol
and 20% PBT overnight. Embryos are mounted onto slides with the dorsal surface
facing up and imaged using a LSM 720 confocal microscope. Microscope settings
for imaging are kept constant from day to day. Embryos are selected for imaging
by looking at the nuclei for signs of the cephalic furrow starting to form to ensure
that all embryos are at the same developmental stage, unless otherwise noted. A
z-stack is selected that is 36 µm wide at 2 µm intervals. Images were saved in a
12bit format for image processing.
2.5.6 Controlling for Staining Variations
In order to quantitate the amount and location of BMP signaling on the dor-
sal surface of the Drosophila embryo, we used antibody staining to p-Mad, the
downstream transcriptional transducer of the Dpp and Scw signals. However, I
noted that the p-Mad antibody is very sensitive to the fixation process making it
difficult to obtain reproducible, consistent staining. In order to develop a method-
ology to control for the quality of staining, we tried four different strategies: 1)
use an internal control in each embryo by looking at the ratio of p-Mad to another
protein (RNA polymerase subunit RPB1) that is expressed at a constant level in
94
all cells (Ratio Method, RM), 2) develop a method to control for variations in
the antibody staining process (Staining Control, SC), 3) perform all staining and
fixation in parallel (Parallel Method, PM), and 4) Develop a method to control
for both the fixation and staining by mixing in wt GFP marked embryos (Mixing
Method, MM).
The RM method takes the ratio of the average intensity of pMad to RNA poly-
merase in a maximum intensity projection of the embryo. This method assumes
that the staining variability will affect all proteins consistently.
The SC method controls for staining variations, but not variations due to
fixation. In the SC method, the control embryos are pre-stained with DAPI or
Propidium iodide (PI) and then mixed with the experimental embryos for pMad
staining. After the embryos are stained they are sorted based on being PI or
DAPI positive vs negative.
The PM method attempts to control for variations in staining due to proce-
dural error. In this method the experimental and control embryos are fixed in
parallel. The embryos were placed in a device that enabled the control and ex-
perimental embryos to be fixed in parallel tubes immersed in the same fixative
solutions. This method was designed to mitigate the differences in the fixation
step.
The MM method controls for staining variations that arise from both the
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fixation and staining. In this method, embryos expressing a Histone-GFP fusion
protein (Gift of Stas Shvartsman) were mixed with experimental embryos and
then fixed and stained within the same tube. After the embryos were imaged, the
control GFP marked embryos were identified by GFP fluorescence. Only embryos
from the same tube are compared for each experimental condition.
2.5.7 pMad Image Analysis
Two methods were used to compare the amount of p-Mad staining. The first
method (Average Method, AM) used an approximation of the total amount of
pMad, which is found by drawing a mask around a maximum intensity projection
of the embryo and finding the average intensity using the LSM 720 imaging soft-
ware. This method gives a fast approximation of the total pMad content and the
maximum intensity of the pMad. However this method does not give any posi-
tional information. This method was used for developing the protocol for studying
the changes in pMad staining.
To compare the width of all the pMad positive nuclei, first a population data
set was obtained for each experimental condition. A Matlab program (described in
[111]) was used to extract the width of p-Mad positive stripe from confocal images.
Briefly, the program realigns the embryos so their A/P axis is horizontally aligned.
The embryos are rescaled to an interval of [0, 1]. Next, the embryos are rotated
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around the AP axis so the dorsal stripe is vertically aligned. A mask is applied
to cover the width of the nuclei where there is pMad staining. A population level
data set is created from the masks for the average and standard deviation of pMad
signaling across the embryo’s length. A student’s t-test with p<0.05 is tested
across the AP axis for areas of significant difference between the 2 populations
being tested. A p<0.00005 was also tested and similar results were found. The
fluorescence intensity from a 12 bit image across the DV axis at relative A/P
positions of 0.25%, 0.5%, and 0.75% embryo length were also compared.
The code from [111] was modified to look at the coefficient of variation (CV) in
the width of pMad positive nuclei across the AP axis between different population
sets. The CV for the width of the pMad across the AP axis was found by taking
the standard deviation/mean for the width of pMad positive nuclei. A student’s
t-test with p<0.05 was applied.
2.5.8 Analysis of Downstream Effects for Loss of Cv-2
The nuclei with high levels of p-Mad signaling posterior to the cephalic furrow
form amnioserosa cells [38]. To determine if the changes in the width of the p-Mad
stripe affects the number of amnioserosa cells formed, 12-24 hour embryo collec-
tions on apple juice plates at 25◦C of Cv-21−/− and His-GFP control embryos
were processed and imaged as described in Section 2.5.5 using a anti-Hindsight
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(HNT) antibody (1:20), a specific marker for amnioserosa cells [116, 117]. The
mouse monocolonal ant-HNT 27B7 IG9 supernatant was obtained from the De-
velopmental Studies Hybridoma Bank funded by NICHD and maintained by The
University of Iowa, Department of Biology, Iowa City, Iowa 52242. The number
of nuclei positive for Hindsight were counted from 24 imaged embryos from both
wt and cv-2 mutants. A student’s t-test with p<0.05 was used to test significance
between the two populations.
Chapter 3
Single Cell Stochastic Model of
BMP Signaling
3.1 Introduction
During embryonic development, an embryo must correctly position, specify, and
grow tissues that will form the adult body. To do this an embryo must make
numerous cell fate decisions in a setting where there can be fluctuations or noise
in its environmental surroundings, protein levels, or genome expression. Cells
can either exploit the fluctuations or have processes that filter or dampen these
fluctuations. For Drosophila melanogaster how the embryo copes with noise is es-
pecially important since it develops externally from its mother. During Drosophila
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early embryonic development, tissues are patterned in a concentration dependent
manner through morphogen gradients. In some cases, the gradient involves a sig-
naling molecule located external to the plasma membrane. In this case, nuclei
must interpret the external concentration of morphogen via a signal transduction
cascade to specify the correct genome expression. One example involves dor-
sal surface patterning, by Bone Morphogenic Protein (BMP) type factors that
are members of the larger Transforming Growth Factor-beta superfamily. BMPs
form a morphogen gradient on the dorsal surface to help specify at least two cell
fates, amnioserosa and dorsal ectoderm. Experimental evidence from cell culture
suggests the active signaling levels for free BMP ligand may be in the picomolar
range. If this is true in vivo then it suggests stochasticity may play a role in
interpretation of BMP gradients. However, the intracellular output of BMP sig-
naling, pMad, forms sharp and reproducible boundaries suggesting that there is
little noise in the system. In this chapter, I examine how noise propagates through
the BMP signaling pathway and what steps in the pathway may either enhance
or filter out noise.
The Drosophila BMP ligands, Decapentapolegic (Dpp), and Screw (Scw) form
a heterodimeric morphogen that specifies the dorsal surface of the Drosophila
embryo. High levels of Dpp/Scw specify amnioserosa, and low to moderate levels
of Dpp/Scw or Dpp homodimers specify dorsal ectoderm in the dorsalmost 40
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Figure 3.1: Model of BMP signaling in the early Drosophila embryo- Module
I: BMP ligand is transported and released by extracellular modulators in the
PV space. The BMP ligand binds to its receptor to activate it. The active
receptor phosphorylates Mad in the cytoplasm. These reactions can occur on the
plasma membrane or in an endocytic vesicle. Module II: Two pMad molecules
combine with Medea to form an active transcription factor and are transported
to the nucleus. Module III: The active transcription factor binds to DNA to
activate transcription. Module IV: Proteins can be produced that can feedback
to modulate the BMP signaling pathway.
BMP signaling during early Drosophila development can be broken into four
general modules: membrane dynamics to create an active signaling complex, cre-
ation of the active transcription factor, nuclear dynamics to create mRNA, and
feedback for upregulating and / or downregulating BMP signaling (Figure 3.1).
On the membrane, BMP signals through a heterodimer of two type I receptors
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and a dimer of a type II receptor [22, 23, 24, 118]. Endocytosis of the bound
receptors is an important step in creating a strong sustained response to BMP
signaling [119]. The active receptor signaling complex phosphorylates the intra-
cellular transcription factor Mad to p-Mad [28]. Two p-Mad molecules combine
with the co-factor Medea and accumulate in the nucleus to regulate transcription
[29]. In the absence of the BMP signal, the Mad, pMad, and Medea proteins
can all shuttle between the nucleus and cytoplasm fairly rapidly. In contrast the
pMad/Medea complex is also be transported into the nucleus, but only monomeric
unphosphorylated Mad or Medea can be exported [120]. This differential translo-
cation leads to the accumulation of the pMad/Medea complex in the nucleus,
where it binds DNA, regulates transcription and controls feedback reactions.
The first mathematical models for DV patterning could not explain the simul-
taneous contraction and intensification of BMP signaling on the dorsal surface.
Wang and Ferguson proposed that a positive feedback loop which increases the
amount of BMP signaling in a local area could account for both the contraction
and intensification of signaling [22], and mathematical models have confirmed
that such a mechanisms could work [52]. However, the mechanistic details remain
obscure, in part because the protein creating the positive feedback has not been
identified. One hypothesis envisions the use of a BMP Surface Binding Protein
(SBP), as an exchange factor. In this model the SBP has a relatively high affinity
102
for both the ligand and receptors such that it can capture and transfer the ligand
to its signaling receptor. In imaginal wing disc development Crossveinless-2 (Cv-
2) has been shown to be such a molecule. It is up-regulated by BMP signaling,
binds ligand and the type I receptor, and stimulates crossvein formation. During
this process, Cv-2 both focuses the BMP signaling output and enhances its signal.
Since Cv-2 is expressed in the early embryo, it was a good candidate to also be
a component of the feedback mechanism that sharpens the BMP gradient at this
stage. However in chapter 2, I showed that Cv-2 is actually a negative regulator of
BMP signaling during dorsal surface pattering. Thus, Cv-2 has different functions
in regulating BMP signaling at different developmental stages, but the nature of
the mechanism responsible for how the contraction and intensification of BMP
signaling takes place in the embryo remains an open question.
Most models for how BMP signaling affects DV patterning have been ana-
lyzed using deterministic mathematical methods. Some models have studied the
BMP transport process in the PV space, which has suggested that one or more
molecules is missing to explain how the BMP gradient is formed [70, 47]. Based
on these models, positive feedback has been proposed as a mechanism to pro-
duce contraction and intensification of the BMP signal around the dorsal midline
[52]. The intracellular dynamics have also been studied to analyze how nuclear
/ cytoplasmic shuttling system can lead to nuclear accumulation of pMad [121].
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Another set of intracellular models have addressed how endocytosis leads to a
strong sustained response from BMP signaling [122, 123, 120]. However if the
concentration of BMP molecules is low, stochastic effects may impact signaling
and, presumably, mechanisms must exist to compensate for noise in the system.
While the amount of Dpp in the PV space has not been quantified, we can make
rough estimates of the average amount of Dpp per nucleus. In cell culture, the
dynamic range for Dpp signaling is 10−10 − 10−9M [50]. The amount of PV fluid
is approximately 500pL. In the early embryo there are approximately 3000 dorsal
nuclei. Thus, the average number of molecules per nucleus is 8 molecules/nucleus
(Equation 3.1).
10−10
moles
L
· 500 ∗ 10−12L · 6.02 ∗ 1023molecules
mole
/3000nuclei = 8molecules (3.1)
However, the actual number of Dpp molecules may be higher at the dorsal midline
and lower in areas away from the midline. Fluctuations in actual numbers in areas
with a lower concentration of molecules may be very important in determining
where the boundary between high and low signaling is located. Thus we choose
to study how these fluctuations may influence the overall BMP signaling network
using a stochastic model.
One study of BMP signaling used stochastic models to examine the dynamics
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of BMP reactions at the membrane [71]. This model assumed that during dorsal
surface patterning, Cv-2 is a primarily a positive regulator of BMP signaling.
However experimental evidence from Chapter 2 suggests that Cv-2 is actually
a negative regulator at this stage. This difference in regulation may affect how
noise propagates through the signaling network. In addition, the stochastic model
proposed that Cv-2 may have a role in filtering out noise. However experimental
evidence suggests that noise at the level of pMad is either not affected or may
be noisier with Cv-2. This model also assumed that the intracellular dynamics
are not stochastic. There are a large number of Mad and Medea molecules in
the cytoplasm [121], which may help attenuate noise in the cytoplasm. However,
this depends upon the phosphorylation rate of Mad. The intracellular dynamics
have not been studied in detail with stochastic models. While there may be noise
attenuation in the cytoplasm, the transcriptional gene activation is a stochastic
process where there are very few DNA binding sites for the transcription factors.
This can lead to transcriptional bursting of mRNA molecules, which may also lead
to protein bursting. This may have a large influence on the temporal evolution
of the signaling network output and possible noise attenuation. Thus a more
detailed stochastic model studying the intracellular dynamics of BMP signaling
is warranted.
We developed a 3-D single cell stochastic model to characterize the downstream
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biological network. By conducting a detailed scale analysis of reaction frequen-
cies and stochastic simulations of the biological system, we seek to understand
how reactions of different time scales affect the propagation of fluctuations in
the network. We hypothesize that endocytosis, large numbers of Mad molecules,
trimer formation of the Mad/coMad complex, nuclear transport, and feedback
of a co-receptor all decrease the amount of noise in the signaling network. This
noise may arise from the low levels of free signaling molecules in the PV space,
slow phosphorylation of Mad in the cytoplasm, or translation of mRNA molecules
from DNA in the nucleus. We also propose that the mechanisms of endocytosis,
trimer formation, and nuclear transport may be ways to integrate the low levels
of BMP signaling over time to create a sustained signal. Our model employs a
prototypical BMP signaling network system, and our conclusions may carry over
to other signaling networks.
3.2 Models
3.2.1 3D Stochastic Model
The single cell model consists of three different domains: the PV space, the cy-
toplasm, and the nucleus. BMP (B) diffusion, production and degradation occur
in the PV space. Near the embryo membrane, the reactions are the insertion
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of receptors (R) at a constant rate, the secretion of Cv-2 (C) after cytoplasmic
translation, endocytosis and exocytosis of receptors, Cv-2, bound receptor (BR),
BMP bound to Cv-2 (BC) and BMP bound to Cv-2 and its receptor (BCR), and
the phosphorylation of the cytoplasmic Mad by BR. We use the endocytosis and
exocytosis mechanism described by[124], in which internalized BR can phospho-
rylate Mad, and BMP will disassociate from its receptor and Cv-2 when BR, BCR
and BC are recycled. Without any quantitative information about intracellular
degradation, we assume the intracellular degradation of BR, BCR, BC, Cv-2 and
R occurs at the same rate as it does in the PV space. The binding reactions
between BMP, R and Cv-2 as in [52] are assumed to occur throughout the PV
space.
Figure 3.2: Single Cell System Geometry- The PV space is a rectangle over the
cytoplasm. The cytoplasm is a box with a sphere (red) for the nucleus in its
center.
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In the cytoplasm, we use the structure of the Smad2 pathway as determine by
studies in human cell lines. Through transgenic experiments, human Smad2 was
found to function in the same way as Mad in Drosophila, and Smad4 works in the
same way as Medea [125]. Without signaling, the Smad2 protein shuttles between
the nucleus and cytoplasm. During signaling, the occupied receptor phosphory-
lates Smad2, which facilitates formation of a Smad/Smad4 and Smad2/Smad2
complexes. The exact structures of the Smad oligomers have not been fully de-
termined. Both types of complexes can be transported into the nucleus, while
dephosphorylated Smad is the only molecule that is exported in the monomeric
form [121, 126]. The differential transport kinetics leads to the accumulation of
pSmad2/pSmad2/Smad4 and pSmad2/Smad2/pSmad2 complexes in the nucleus,
where they can bind to DNA, regulate transcription and control feedback reac-
tions. Therefore, the reactions in the cytoplasm are the phosphorylation of Mad,
the association and dissociation reactions between pMad and Medea, the synthesis
of Cv-2 from mRNA translation, the degradation of mRNA, and the intracellular
degradation of BR, BCR, BC and Cv-2. For simplicity, we denote pMad/Medea
as pMMe and pMad/pMad as pMad2. Near the nuclear membrane, the reactions
are the nuclear export and import of Mad, pMad, and Medea, the unidirectional
import of pMad2 and pMMe, and the nuclear export of mRNA.
It has been suggested that the transcription factors are actually not dimers
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(Smad2/Smad2 or Smad2/Smad4) but are hetero-trimers consisting of two pS-
mad2’s and one Smad4 [127]. Moreover, our estimation in the following section
shows the amount of Mad and Medea are likely much larger than is necessary for
pMad and pMad/Madea to activate the downstream gene expressions. So we use
the trimer as the transcription factor.
The reactions in the nucleus are the dephosphorylation of pMad, the associ-
ation and dissociation reactions between pMad and Medea, the binding and un-
binding reactions between the transcription factors and the promoter site, and the
production of mRNA. During transcription, we divide the production of mRNA
into two steps: 1) RNA polymerase (RNAp) binds to the DNA sequence to form
an elongation complex, RNAt; 2) RNAt proceeds to become mRNA. Depending
on the status of the promoter site, the formation rate of RNAt switches between
a basal rate and an enhanced rate, while RNAt always proceeds at the same rate.
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Figure 3.3: Reaction network-Blue and Yellow are reactions in the PV space.
Green is reactions in the cytoplasm. Red is reactions in the nucleus
The reaction network is shown in Figure 3.3. In addition, we make the follow-
ing assumptions:
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1. Only the species that can be produced undergo degradation. Therefore,
BMP, R, Cv-2, BR, BC, BCR and mRNA undergo degradation, and the
total amount of Mad and Medea in all forms is constant.
2. Proteins synthesized from mRNA translation can be transported actively
and rapidly to their end-destination. So we approximate the transport of
proteins synthesized from mRNA translation either as fast cytoplasmic dif-
fusion with a large flux into the PV space or as direct random insertion into
the PV space.
3. All species except DNA and proteins synthesized from mRNA translation
diffuse. DNA is kept at the center of the nuclear sphere.
Initially, the concentration of each species is set to zero except the following
ones:
1. The concentrations of the receptors in the PV space and the cytoplasm are
160nM in order to be consistent with the endocytosis and exocytosis rates
[52, 124];
2. The concentrations of the cytoplasmic Mad and Medea are the concentra-
tions from [121], i.e., the concentrations of the cytoplasmic Mad and Medea
are 15.1nM and 12.7nM respectively;
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3. The concentrations of the nuclear Mad and Medea are the concentrations
from [121], i.e., the concentrations of the nuclear Mad and Medea are 7.125nM
and 12.7nM respectively.
The deterministic equations of the system can be written as below. The general
form for each reaction is
∂X
∂t
= DX∆[Xi] +R(X) (3.2)
where ∂X
∂t
is the rate of change of X with respect to both position and time,
DX∆[Xi] is diffusion of X in the ith compartment, and R(X) are the reactions
involving X. Without specification, the boundary conditions are Neumann bound-
ary condition. The following equations describe the evolution of the molecules in
the PV space:
∂[Bp]
∂t
= DBp∆[Bp] + sB − k4[Bp][Cp] + k−4[BCp]− k5[Bp][Rp]
+ k−5[BRp]− dBp[Bp] (3.3a)
∂[Cp]
∂t
= DCp∆[Cp]− k4[Bp][Cp] + k−4[BCp]− k7[BRp][Cp]
+ k−7[BCRp]− dCp[Cp] (3.3b)
∂[Rp]
∂t
= DRp∆[Rp] + sR(x, y, z)− k5[Bp][Rp] + k−5[BRp]− k6[BCp][Rp]
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+ k−6[BCRp]− dRp[Rp] (3.3c)
∂[BCp]
∂t
= DBCp∆[BCp] + k4[Bp][Cp]− k−4[BCp]− k6[BCp][Rp]
+ k−6[BCRp]− dBCp[BCp] (3.3d)
∂[BRp]
∂t
= DBRp∆[BRp] + k5[Bp][Rp]− k−5[BRp]− k7[BRp][Cp]
+ k−7[BCRp]− dBRp[BRp] (3.3e)
∂[BCRp]
∂t
= DBCRp∆[BCRp] + k6[BCp][Rp]− k−6[BCRp] + k7[BRp][Cp]
− k−7[BCRp]− dBCRp[BCRp] (3.3f)
Near the cytoplasmic membrane the following fluxes occur:
−DCc∂[Cc]
∂z
= −kex[Cc] + ken[Cp], (3.4a)
−DCp∂[Cp]
∂z
= −ken[Cp] + kex[BCc] + kex[BCRc] + kex[Cc] + kse[Tc], (3.4b)
−DTc∂[Tc]
∂z
= −kse[Tc], (3.4c)
−DRc∂[Rc]
∂z
= −kex[Rc] + ken[Rp], (3.4d)
−DRp∂[Rp]
∂z
= −ken[Rp] + kex[BRc] + kex[BCRc] + kex[Rc], (3.4e)
−DBCc∂[BCc]
∂z
= −kex[BCc] + ken[BCp], (3.4f)
−DBCp∂[BCp]
∂z
= −ken[BCp], (3.4g)
−DBRc∂[BRc]
∂z
= −kex[BRc] + ken[BRp], (3.4h)
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−DBRp∂[BRp]
∂z
= −ken[BRp], (3.4i)
−DBCRc∂[BCRc]
∂z
= −kex[BCRc] + ken[BCRp], (3.4j)
−DBCRp∂[BCRp]
∂z
= −ken[BCRp]. (3.4k)
The following reactions describe how the molecules evolve in the cytoplasm:
∂[Madc]
∂t
= DMadc∆[Madc]− kphos ([BRc] + δ(z − z0)[BRp]) [Madc] (3.5a)
∂[pMadc]
∂t
= DpMadc∆[pMadc] + kphos ([BRc] + δ(z − z0)[BRp]) [Madc]
− k8[pMadc]2 + k−8[pMad2c]
− k8[pMadc][Medeac] + k−8[pMMec]
− k8[pMadc][pMMec] + k−8[pM3c] (3.5b)
∂[Medeac]
∂t
= DMedeac∆[Medeac]
− k8[pMadc][Medeac] + k−8[pMMec]
− k8[pMad2c][Medeac] + k−8[pM3c] (3.5c)
∂[pMad2c]
∂t
= DpMad2c∆[pMad2c] + k8[pMadc]
2 − k−8[pMad2c]
− k8[pMad2c][Medeac] + k−8[pM3c] (3.5d)
∂[pMMec]
∂t
= DpMMec∆[pMMec]
+ k8[pMadc][Medeac]− k−8[pMMec]
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− k8[pMMec][pMadc] + k−8[pM3c] (3.5e)
∂[pM3c]
∂t
= DpM3c∆[pM3c] (3.5f)
+ k8[pMad2c][Medeac]− k−8[pM3c]
+ k8[pMMec][pMadc]− k−8[pM3c] (3.5g)
∂[Tc]
∂t
= DTc∆[Tc] + kTpro[RNAc] (3.5h)
∂[RNAc]
∂t
= DRNAc∆[RNAc]− dRNAc[RNAc] (3.5i)
∂[Cc]
∂t
= DCc∆[Cc]− dCc[Cc] (3.5j)
∂[Rc]
∂t
= DRc∆[Rc]− dRc[Rc] (3.5k)
∂[BCc]
∂t
= DBCc∆[BCc]− dBCc[BCc] (3.5l)
∂[BRc]
∂t
= DBRc∆[BRc]− dBRc[BRc] (3.5m)
∂[BCRc]
∂t
= DBCRc∆[BCRc]− dBCRc[BCRc] (3.5n)
The following equations describe the fluxes across the nuclear membrane:
−DMadc∂[Madc]
∂n
= −kin[Madc] + kout[Madn], (3.6a)
−DMadn∂[Madn]
∂n
= kin[Madc]− kout[Madn] (3.6b)
−DpMadc∂[pMadc]
∂n
= −kin[pMadc] + kout[pMadn], (3.6c)
−DpMadn∂[pMadn]
∂n
= kin[pMadc]− kout[pMadn], (3.6d)
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−DpMadc∂[Medeac]
∂n
= −kin[Medeac] + kmout[Medean], (3.6e)
−DMedean∂[Medean]
∂n
= kin[Medeac]− kmout[Medean], (3.6f)
−DpMad2c∂[pMad2c]
∂n
= −kdin[pMad2c], (3.6g)
−DpMad2n∂[pMad2n]
∂n
= kdin[pMad2c], (3.6h)
−DpMMec∂[pMMec]
∂n
= −kdin[pMMec], (3.6i)
−DpMMen∂[pMMen]
∂n
= kdin[pMMec], (3.6j)
−DpM3c∂[pM3c]
∂n
= −kdin[pM3c], (3.6k)
−DpM3n∂[pM3n]
∂n
= kdin[pM3c], (3.6l)
−DRNAc
∂[RNAc]
∂n
= krout[RNAn], (3.6m)
−DRNAn
∂[RNAn]
∂n
= −krout[RNAn]. (3.6n)
The following equations describe the evolution of the molecules in the nucleus:
∂[Madn]
∂t
= DMadn∆[Madn] + kdephos[pMadn] (3.7a)
∂[pMadn]
∂t
= DpMadn∆[pMadn]− kdephos[pMadn] (3.7b)
− k8[pMadn]2 + k−8[pMad2n]
− k8[pMadn][Medeac] + k−8[pMMen]
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− k8[pMadn][pMMen] + k−8[pM3n] (3.7c)
∂[Medean]
∂t
= DMedean∆[Medean]
− k8[pMadn][Medean] + k−8[pMMen]
− k8[pMad2n][Medean] + k−8[pM3n] (3.7d)
∂[pMad2n]
∂t
= DpMad2n∆[pMad2n] + k8[pMadn]
2 − k−8[pMad2n]
− k8[pMad2n][Medean] + k−8[pM3n] (3.7e)
∂[pMMen]
∂t
= DpMMen∆[pMMen]
+ k8[pMadn[Medea]− k−8[pMMen]
− k8[pMMen][pMadn] + k−8[pM3n] (3.7f)
∂[pM3n]
∂t
= DpM3n∆[pM3n] (3.7g)
+ k8[pMad2n][Medean]− k−8[pM3n]
+ k8[pMMen][pMadc]− k−8[pM3n] (3.7h)
∂[DNAn]
∂t
= −k9[DNAn][pM3n] + k−9[NDNAn] (3.7i)
∂[NDNAn]
∂t
= k9[DNAn][pM3n]− k−9[NDNAn] (3.7j)
∂[RNAtn]
∂t
= kbT [DNAn] + keT [NDNAn]− kT [RNAtn] (3.7k)
∂[RNAn]
∂t
= DRNAn∆[RNAn] + kT [RNAtn] (3.7l)
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3.2.2 Computation for 3D Stochastic Model
The simulation is done using Urdme version 1.1 [128]. Urdme is an open source
3-dimensional stochastic simulation software package. The model geometry is
built and discretized in Comsol Multiphysics (Figure 3.4). The 3-D system is
discretized into 445 tetrahedrons with the maximal length less than 3µm. Then
model geometry is exported and brought into Matlab. In Matlab the stochastic
simulation is run using the mesh generated from Comsol Multiphysics.
Figure 3.4: Discretization of the Single Cell Stochastic Model in Comsol
Multiphysics- The model was discretized into 445 tetrahedrons in Comsol Multi-
physics.
The reaction and diffusion rates are defined in the same way as the conventional
118
spatial Gillespie simulation method. Moreover, the reaction rates are chosen based
on the discretization of the deterministic model. For example, in a tetrahedron
with length h and volume V , the deterministic governing of Cp is as follows:
∂[Cp]
∂t
= DCp∆[Cp]− k4[Bp][Cp] + k−4[BCp]− k7[BRp][Cp] + k−7[BCRp]− dCp[Cp],
and the reactions with Cp involved happen with the rates in Table 3.1.
Reaction Rates in Terms in the
stochastic simulation deterministic model
Bp + Cp
k4−→ BCp (k4[#Bp][#Cp])/(VNA) −k4[Bp][Cp]
BCp
k−4−−→ Cp +Bp k−4[#BCp] k−4[BCp]
BRp + Cp
k7−→ BCRp (k7[#BRp][#Cp])/(VNA) −k7[BRp][Cp]
BCRp
k−7−−→ Cp +BRp (k−7[#BCRp]) k−7[BCRp]
Diffusion [#C] ∗DCp/h2 DCp∆[Cp]
Table 3.1: Relation Between the Stochastic and Deterministic Reaction Rates-
The relation between the Deterministic and Stochastic reaction and diffusion rates
are described for all reactions involving C in the PV space h and V are the length
of volume of the tetrahedron where the reaction is occurring. NA is Avagadro’s
number.
If the tetrahedron is near the cytoplasm membrane, the transport of Cp is
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controlled by the following flux equation in the deterministic model.
−DCp∂[Cp]
∂z
= −ken[Cp] + kex[BCc] + kex[BCRc] + kex[Cc] + kse[Tc].
In stochastic simulation, the transport reactions occur as described in Table
3.2.
Reaction Rates in Terms in the
stochastic simulation deterministic model
Cp
ken−−→ Cc (ken[#Cp])/(h) −ken[Cp]
BCc
kex−−→ Cp (kex[#BCc])/(h) kex[BCc]
BCRc
kex−−→ Cp (kex[#BCRc])/(h) kex[BCRc]
Cc
kex−−→ Cp (kex[#Cc])/(h) kex[Cc]
Tc
kex−−→ Cp (kex[#Tc])/(h) kex[Tc]
Table 3.2: Relation Between the Transport Reactions in the Deterministic and
Stochastic Simulation- The relation for the transport rates across the plasma
membrane for all reactions involving C between the deterministic and stochastic
models. h is the length of the tetrahedron where the flux is occurring. The
transport rates are modified for all other parameters in the same way.
Table 3.3 describes the abbreviations used in the stochastic and deterministic
models.
120
Symbol Description
*p Species in the PV space
*c Species in the Cytoplasm
*n Species in the nucleus
B BMP
C Surface bound protein
R Receptor
BR BMP bound to its Receptor
BC BMP bound to C
BCR Complex ofBMP bound to C and R
Mad Mad
pMad Phosphorylated Mad
pMad2 The homodimer of pMad
Me Medea
pMMe The heterodimer of pMad and Medea
pM3 The trimer of two pMads and one Medea
T C produced from translation
DNA Free DNA sequence
NDNA DNA occupied by trimer
RNA mRNA
RNAt Polymerase formed during transcription
Table 3.3: Species Used in the Single Cell Stochastic Model
Table 3.4 describes the reaction rates used in the single cell stochastic model.
The reaction rates were taken from experimental estimations whenever possible.
Otherwise reaction rates were taken from other mathematical models or estimated.
The same approach was applied for finding diffusion coefficients. The diffusion
coefficients used in the model are described in Table 3.5.
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Reactions Rate constants References
Receptor Intereactions
Bp + Cp
k4−−⇀↽−
k−4
BCp k4 = 1
1
nM∗min , k−4 = 2
1
min
[52]
Bp +Rp
k5−−⇀↽−
k−5
BRp k5 = 2.4 ∗ 10−2 1nM∗min , k−5 =
4 1
min
[52]
BCp +Rp
k6−−⇀↽−
k−6
BCRp k6 = 5 ∗ 10−1 1nM∗min , k−6 =
10 1
min
[52]
BRp + Cp
k7−−⇀↽−
k−7
BCRp k7 = 1.3 ∗ 10−1 1nM∗min , k−7 =
10 1
min
[52]
Endocytosis
Cp
ken−−→ Cc, Rp ken−−→ Rc ken = 3.3 ∗ 10−2 µmmin [129]
BCp
ken−−→ BCc, BRp ken−−→ BRc
BCRp
ken−−→ BCRc
Excytosis
Cc
kex−−→ Cp, Rc kex−−→ Rp kex = 3.3 ∗ 10−3 µmmin [129]
BCc
kex−−→ Cp, BRc kex−−→ Rp
BCRc
kex−−→ Rp + Cp
Secretion
Tc
kse−→ Cp kse = 3 µmmin Estimated
Cytoplasmic Intereactions
Madc
kphos·[BRc]−−−−−−→ pMadc kphos = 2.4 ∗ 10−2 1nM∗min [121]
Madc
kphos·[BRp]−−−−−−→ pMadc
2pMadc
k8−−⇀↽−
k−8
pMad2c k8 = 1.1 ∗ 10−1 1nM∗min , k−8 =
1 1
min
[121]
pMadc +Medeac
k8−−⇀↽−
k−8
pMMec
pMad2c +Medeac
k8−−⇀↽−
k−8
pM3c
pMMec + pMadc
k8−−⇀↽−
k−8
pM3c
∅
kTpro·[RNAc]−−−−−−−−→ Tc kTpro = 2.4 ∗ 102 nMmin [130]
Nuclear/Cytoplamic
Transport
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Madc
kin−−→Madn kin = 4.5 ∗ 10−1 µmmin [121]
pMadc
kin−−→ pMadn
Medeac
kin−−→Medean
pMad2c
kdin−−→ pMad2n kdin = 2.7 µmmin [121]
pMMec
kdin−−→ pMMen
pM3c
kdin−−→ pM3n
Madn
kout−−→Madc kout = 1 µmmin [121]
pMadn
kout−−→ pMadc
Medean
kmout−−−→Medeac kmout = 4.5 ∗ 10−1 µmmin [121]
RNAn
krout−−−→ RNAc krout = 100 µmmin Estimated
Nuclear Reactions
pMadn
kdephos−−−−→Madn kdephos = 3.96 ∗ 10−1 1min [121]
2pMadn
k8−−⇀↽−
k−8
pMad2n k8 = 1.1 ∗ 10−1 1nM∗min , k−8 =
1 1
min
[121]
pMadn +Medean
k8−−⇀↽−
k−8
pMMen
pMad2n +Medean
k8−−⇀↽−
k−8
pM3n
pMMen + pMadn
k8−−⇀↽−
k−8
pM3n
pM3n +DNAn
k9−−⇀↽−
k−9
NDNAn k9 = 600
1
nM∗min , k−9 = 67
1
min
[131]
∅ kbT ·[DNAn]−−−−−−−→ RNAtn kbT = 6 1min [130]
∅ keT ·[NDNAn]−−−−−−−−→ RNAtn keT = 180 1min [130]
RNAtn
kT−→ RNAn kT = 10 1min Estimated
Reactions not on the figure
∅ sB−→ Bp sB = 1 nMmin Estimated
B
dBp−−→ ∅ dBp = 3.3 ∗ 10−2 1min [52]
∅ sR−→ Rp sR = 5 ∗ 10−4 nMmin Estimated
Rp
dRp−−→ ∅, Rc dRc−−→ ∅ dRp = dRc = 5 ∗ 10−4 1min [52]
Cp
dCp−−→ ∅, Cc dCc−−→ ∅ dCp = dCc = 1.67 ∗ 10−4 1min [52]
BRp
dBRp−−−→ ∅, BRc dBRc−−−→ ∅ dBRp = dBRc = 1.67 ∗ 10−4 1min [52]
BCp
dBCp−−−→ ∅, BCc dBCc−−−→ ∅ dBCp = dBCc = 1.67 ∗ 10−4 1min [52]
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BCRp
dBCRp−−−−→ ∅, BCRc dBCRc−−−→ ∅ dBCRp = dBCRc = 1.67 ∗
10−4 1
min
[52]
RNAc
dRNAc−−−−→ ∅ dRNAc = 6.6 1min [132]
Table 3.4: Reaction Rates Used in the Single Cell Stochastic Model- The table
lists the base set of reactions used in the model. All reaction rates can be assumed
to be the same as in the table unless noted otherwise in the text. Reaction rates
were taken from experimental estimation whenever possible. If no experimental
data was available, reaction rates were taken from other mathematical models,
and if those were not available the rates were estimated.
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Species Diffusion Coefficients References
PV space
Bp DBp = 73µm
2/s [52]
Cp DCp = 1.7µm
2/s Estimated
Rp DRp = 1.3µm
2/s Estimated
BCp DBCp = 1.5µm
2/s Estimated
BRp DBRp = 1.2µm
2/s Estimated
BCRp DBCRp = 1.1µm
2/s Estimated
Cytoplasm
Madc DMadc = 16µm
2/s Estimated
pMadc DpMadc = 16µm
2/s Estimated
Medeac DMedeac = 14µm
2/s Estimated
pMad2c DpMad2c = 13µm
2/s Estimated
pMMec DpMMec = 12µm
2/s Estimated
pM3c DpM3c = 10.5µm
2/s Estimated
Tc DTc = 100µm
2/s Estimated
RNAc DRNAc = 0.03µm
2/s [133, 134]
Cc DCc = 12µm
2/s Estimated
Rc DRc = 9.5µm
2/s Estimated
BCc DBCc = 10µm
2/s Estimated
BRc DBRc = 8.8µm
2/s Estimated
BCRc DBCRc = 7.8µm
2/s Estimated
Nucleus
Madn DMadn = 16µm
2/s Estimated
pMadn DpMadn = 16µm
2/s Estimated
Medean DMedean = 14µm
2/s Estimated
pMad2n DpMad2n = 13µm
2/s Estimated
pMMen DpMMen = 12µm
2/s Estimated
pM3n DpM3n = 10.5µm
2/s Estimated
RNAn DRNAn = 0.03µm
2/s [133, 134]
Table 3.5: Diffusion Coefficients Used in the Single Cell Stochastic Model- The
table lists the base set for diffusion coefficients used in the model. All diffusion
coefficients can be assumed to be the same as in the table unless noted otherwise in
the text. Diffusion coefficients were taken from experimental estimation whenever
possible. If no experimental data was available diffusion coefficients where taken
from other mathematical models, and if those were not available the diffusion
coefficients were estimated.
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3.2.3 Simplified Model
I created a simplified model of BMP signaling. Table 3.6 describes the reactions
in the model and the reaction rates that are modified from the full stochastic
model. Reactions involving R were made into pseudo-first order reaction rates
by multiplying the rate constant by 160nM for the concentration of R. In the
simplified model we adjusted the C production rate to be on the same order of
magnitude as BR. All species in the system start at zero at t = 0. The reactions for
B, BR, and C all take place in the PV space of volume V1 = 40.5µm
3. The reaction
for pMad takes place in the nucleus of volume V3 = 268µm
3. The reaction for
mRNA takes place in the cytoplasm with volume V2 = 461µm
3. The simulations
are solved using the Gillespie algorithm with a code modified from [135] and were
run in Matlab. The output of the mean number of molecules and the CV of the
parameter scan was averaged over the last 10 simulation points after the system
reached steady state. 50 simulations were run for each parameter set.
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Reactions Rate constants
∅ k1−→ B k1 = 10 nMmin
B
k2−→ BR k2 = 3.84 1min
BR
k3−→ BR + pMad k3 = 1.22 1min
pMad
k4−→ pMad+mRNA k4 = 0.6 1min
mRNA
k5−→ mRNA+ C k5 = 0.24 1min
B + C
k6−→ BC k6 = 1 1nMmin
BC
k−6−−→ B + C k−6 = 2 1min
BC
k7−→ BR + C k7 = 80 1min
BR + C
k−7−−→ BC k−7 = 10 1nMmin
B
kd1−−→ ∅ kd1 = 0.033 1min
BR
kd2−−→ ∅ kd2 = 0.033 1min
pMad
kd3−−→ ∅ kd3 = 0.396 1min
mRNA
kd4−−→ ∅ kd4 = 6.6 1min
C
kd2−−→ ∅ kd2 = 0.033 1min
BC
kd2−−→ ∅ kd2 = 0.033 1min
Table 3.6: Reactions in Simplified Stochastic Model
3.3 Results
3.3.1 Time Scales of Reactions
In this section we compare time scales of different reaction steps to understand
the temporal scale of signal evolution. We first estimate the maximal numbers of
molecules of different species based on literature, and then use them to estimate
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reaction frequencies. We find that the major rate limiting steps are phosphoryla-
tion of Mad and the nucleocytoplasmic transport of mRNA.
We first estimate the maximal number of molecules of each species in the PV
space, cytoplasm and nucleus in order to understand possible areas of stochasticity.
For free BMP, the estimated concentration from previous models on the dorsal
surface at maximal signaling is around 5nM [52]. The PV space above one nucleus
is approximately approximately 9µm × 0.5µm × 9µm. The maximal number of
BMP molecules in the PV space based upon the Umulis model is
5 ∗ 10−9M × 6.02× 1023molecules
mol
× 9µm× 9µm× 0.5µm ∗ 10
−15L
µm3
= 122. (3.8)
This is an order of magnitude higher than estimates from cell culture. However the
estimates from cell cultures are an average over all dorsal nuclei and do not take
into account any transport of molecules towards the dorsal midline. Even taking
transport of molecules into account, the level of free BMP is within a stochastic
range.
For simplicity of modeling it is assumed that receptors are distributed in the
whole PV space as in [52]. Therefore the maximal number of receptors in the PV
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space is
160∗10−9M×6.02×1023molecules
mol
×9µm×9µm×0.5µm∗ 10
−15L
µm3
= 3900, (3.9)
where the concentration of receptors 160nM is taken from [52]. Similarly, the
maximal numbers of molecules of other species can be estimated. Table 3.7 shows
the maximal number of molecules of species in the PV space, cytoplasm, and
nucleus. We denote BMP as B, receptors are as R and a surface binding molecule
similar to Cv-2 as C. In addition, to differentiate molecules in different locations,
we use *p, *c and *n to denote the species in the PV space, the cytoplasm and
the nucleus respectively. For example, Bp represents B in the PV space and Bc
represents B in the cytoplasm. The total amount of receptors and Cp molecules
is much larger than the amount of Bp. This may allow Cp and the receptors to
bind Bp more effectively and possibly attenuate fluctuations in Bp. The number
of molecules in the system varies by several orders of magnitude. The species with
large numbers of molecules may be able to attenuate the noise in B and BR where
there are significantly less molecules.
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Variable Description Number of Molecules Reference
B BMP ligand 122 molecules [52, 50]
BR Bound Receptor 730 molecules [52]
R BMP receptors 3900 molecules [52]
C Surface Binding Protein 8400 molecules [52]
Mad Mad 22, 300 [52]
Medea Medea 22, 300 [52]
Table 3.7: Maximum Estimated Number of Molecules- We estimate the maximal
number of molecules in the system predicted from previous models of BMP signal-
ing. There is a wide range of estimated number of molecules in the system. The
level of free B molecules suggests that reactions involving B may be stochastic.
We next investigated the likelihood a reaction will occur in the system. To
estimate reaction frequencies, we calculated the maximal propensity function of
each reaction, which gives the largest probability of the occurrence of the reaction
per unit time. In particular, we calculate the propensity function by Eq. (3.10)
X1 ×X2 × rate× V × 6.02× 1023, (3.10)
where X1 and X2 are the concentrations of the reactant species in a bimolecular
reaction (X2 = 1 for a unimolecular reaction), rate is the reaction rate constant,
and V is the volume of the respective cuboid. X1 and X2 are chosen as the max-
imal concentrations of the reactant species in the cuboid. Table 3.8 summaries
the propensity functions of selected reactions. There is a two orders of magnitude
difference between the slowest and fastest reactions in the PV space. Forming
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active signaling complexes by B binding to R is very slow, but the formation of
active signaling complexes through binding to C is very likely, leading to almost
all active signaling complexes forming through C. In the intracellular space, the
major rate limiting step appears to be the phosphorylation of Mad to pMad. This
is somewhat surprising because based on the maximal number of molecules anal-
ysis, since the number of Mad molecules is very high, which would suggest that
it should not be a slow step. However the estimated phosphorylation rate is very
slow, making the overall likelihood that the reaction occurs low. Since we calcu-
lated the maximal reaction propensities, the actual propensity of an individual
reaction as the system evolves may be much slower. Thus some of the reactions
estimated to be more likely to occur may initially occur less frequently until the
maximal concentration of reactants is reached. The reaction propensity analysis
suggests that the binding of B to its receptor, the phosphorylation of Mad, and
the disassociation of the transcription factors are slow steps in the system.
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Reaction Species 1 Species 2 Rate Propensity
(Max
Conc)
(Max
Conc)
Function
B + C → BC B (5nM) C
(200nM)
1.66 ∗ 107 1
M∗sec 405
1
sec
BC → B + C BC
(30nM)
0.33 1
sec
241 1
sec
BC +R→ BCR BCR
(30nM)
R
(160nM)
8.33 ∗ 106 1
M∗sec 975
1
sec
BCR→ BC +R BCR
(80nM)
0.17 1
sec
332 1
sec
BR + C → BCR BR
(30nM)
C
(200nM)
2.17 ∗ 106 1
M∗sec 317
1
sec
BCR→ BR + C BCR
(80nM)
0.17 1
sec
332 1
sec
B +R→ BR B (5nM) R
(160nM)
4.00 ∗ 105 1
M∗sec 8
1
sec
BR→ B +R BR
(30nM)
0.067 1
sec
490 1
sec
BR +Mad→ pMad BR
(30nM)
Mad
(50.8nM)
4 ∗ 105 1
M∗sec 15
1
sec
BCR+Mad→ pMad BCR
(80nM)
Mad
(50.8nM)
4 ∗ 105 1
M∗sec 40
1
sec
pMad + pMad →
pMad2
pMad
(50.8nM)
pMad
(50.8nM)
1.8 ∗ 106 1
M∗sec 113
1
sec
pMad+Me→ pMMe pMad
(50.8nM)
Me
(50.8nM)
1.8 ∗ 106 1
M∗sec 113
1
sec
pMad2→ 2pMad pMad2
(25.4nM)
0.016 1
sec
10 1
sec
pMMe→ pMad+Me pMMe
(50.8nM)
0.016 1
sec
20 1
sec
pMad→Mad pMad
(50.8nM)
0.0066 1
sec
8 1
sec
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Table 3.8: Propensity Function for Selected Reactions- We calculated the max-
imum likelihood a reaction will occur based on maximum concentrations of
molecules from previous published models. For reactions that are not listed, con-
centration estimates are not available. The rate limiting steps appear to be the
binding of B to R, the phosphorylation of Mad to pMad, and the disassociation of
the pMad complexes. The fastest reactions are reactions involving the molecule
C.
We also studied the maximal propensity for transport of molecules across the
plasma and nuclear membrane. The maximal propensity function for membrane
transport is calculated by Eq. (3.11)
X1 × rate× V × 6.02× 1023 (3.11)
where X1 is the maximal concentration of the respective species, rate is the trans-
port rate constant, and V is the volume of the compartment where the transport
starts. For the membrane transport propensity analysis we assume all molecules
are evenly distributed in their respective compartments in the PV space, cy-
toplasm, or nucleus. Therefore, we use the total number of molecules in the
compartment in Eq. (3.11). Table 3.9 summarizes the propensity functions for
transport across membranes. Transport across the plasma membrane represents
endocytosis and transport across the nuclear membrane is nuclear-cytoplasmic
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shuttling. The transport propensities are several orders of magnitude slower than
the molecular reaction propensities. Transport of molecules across membranes
may be rate limiting steps in the BMP signaling pathway.
Species Concentration Rate Propensity
Function
Transport Across
Plasma Membrane
BR BR (30nM) 3.33 ∗ 10−4 1
sec
0.244 1
sec
B B (5nM) 3.33 ∗ 10−4 1
sec
0.0406 1
sec
C C (200nM) 3.33 ∗ 10−4 1
sec
1.62 1
sec
BCR BCR (80nM) 3.33 ∗ 10−4 1
sec
0.650 1
sec
R R (160nM) 3.33 ∗ 10−4 1
sec
1.30 1
sec
Transport Across
Nuclear Membrane
Madc Mad (50.8nM) 5.16 ∗ 10−3 1sec 0.0728 1sec
Madn Mad (50.8nM) 0.29
1
sec
2.38 1
sec
pMadc pMad (50.8nM) 5.16 ∗ 10−3 1sec 0.0728 1sec
pMadn pMad (50.8nM) 0.29
1
sec
2.38 1
sec
pMad2c pMad2 (25.4nM) 0.0294
1
sec
0.207 1
sec
pMMen pMMe (50.8nM) 0.0294
1
sec
0.415 1
sec
Mec Me (50.8nM) 0.00516
1
sec
0.0728 1
sec
Men Me (50.8nM) 0.00305
1
sec
0.02502 1
sec
Table 3.9: Propensity Function for Transport Across Membranes- We estimate
the maximal propensity for molecules to move across the plasma or nuclear mem-
brane. The propensity for transport across membranes is much smaller than the
propensity for molecular reactions.
Finally we estimate the time scale for a molecule to diffuse throughout the PV
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space, cytoplasm, or nucleus. The time scale is estimated by Eq (3.12)
L2
D
(3.12)
where D is the diffusion coefficient, and L is the maximum length of the PV
space, cytoplasm, or nucleus. Table 3.10 summarizes the time scales for selected
molecules in their respective compartments. The diffusion of mRNA is several
orders of magnitude slower than all other diffusion processes. Therefore, the
transport of mRNA can also be a limiting step in the signal evolution. However
with the exception of mRNA, the diffusion rates are fast and diffusion is not a
rate limiting step in the interaction of molecules in the system.
Species Diffusion L2/D
Constant
B 7.3 ∗ 10−11m2
sec
1.1s
R 1.3 ∗ 10−12m2
sec
62.3s
pMadc 1.6 ∗ 10−11m2sec 5.06s
mRNAc 3.0 ∗ 10−14m2sec 2700s
pMadn 1.6 ∗ 10−11m2sec 4s
mRNAn 3.0 ∗ 10−14m2sec 2130s
Table 3.10: Diffusion Time Scale Analysis- The length scales for diffusion of se-
lected molecules in the BMP signaling pathway was estimated. Overall the diffu-
sion rate is fairly fast with the exception of mRNA. The overall diffusion of mRNA
is a slow step and may affect its transport from the nucleus to the cytoplasm.
The BMP signaling pathway is a multi-scale network, which allows us to reduce
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the system for stochastic simulations. Since the diffusion time of Mad and Medea
is much less than the time of phosphorylation and nuclear transport, we can
assume that Mad and Medea are always well mixed in the nucleus and cytoplasm.
By making this assumption, we can reduce the simulation time by half to one
third. Since the phosphorylation of Mad is much slower than other reactions that
implies there may be a small number of pMad molecules with large fluctuations in
the cytoplasm. Furthermore, the nucleocytoplasmic transport of mRNA is much
slower than other reactions and diffusion processes, which may introduce noise in
the feedback process of BMP signaling. The concentration and time-scale analysis
indicates there are species with low numbers of molecules and several slow steps
in the reaction system, which suggests that stochasticity may play a role in the
BMP signaling pathway.
3.3.2 3-D Single Cell Stochastic Model
Temporal Evolution of the System
We simulate the biochemical system presented in Section ?? using the base pa-
rameter set found in table 3.4. Figure 3.5 shows the evolution of the system for
one realization and Figure 3.6 shows the mean and coefficient of variation (CV) of
selected molecules in different domains of the stochastic system. The coefficient
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of variation is defined as the standard deviation/mean and is a way to measure
noise in the system. A larger CV indicates more noise is present. The system
has some noise as the trajectories in Figure 3.5 are not smooth. B represents
free BMP molecules. BR is the active signaling complex where B is bound to its
receptor. C represents a co-receptor, Cv-2, for B. pMad is the phosphorylated
Mad molecule which arises from Mad interacting with BR. The pMad molecules
can form a dimer, pMad2; a complex with Medea, pMMe; or a trimer of 2 pMads
and one Medea, pM3. The active transcription factor pM3 can bind to the DNA
promoter site to turn on transcription. When this occurs the DNA promoter sites
goes from unoccupied (1) to bound (0). RNA is produced and diffuses to the
cytoplasm where translation produces Cv-2. Cv-2 starts at zero in the system
and is produced at a low basal rate that is significantly increased from activation
of the BMP signaling cascade. This series of molecular interactions captures the
main elements in the canonical BMP signaling pathway.
The receptor dynamics follow different trajectories for the mean amount of
molecules and the CV for the respective species in the PV space and cytoplasm
(Figure 3.6). The level of free BMP slowly decreases to almost zero as the system
evolves since all the BMP produced immediately binds to either Cv-2 or BR
(Figure 3.6 A). While the overall CV for BMP is fairly low, the CV increases as
the system evolves because of the low mean (Figure 3.6 A). BR increases in the PV
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space until the amount of Cv-2 produced starts to dramatically increase around
40 minutes (Figure 3.6 B). Cv-2 acts as an inhibitor of signaling by sequestering
and competing for BMP. When the amount of BR starts to decrease the CV of
BR starts to increase (Figure 3.6 B). However, for the endocytosed BR the levels
are still increasing at 60 minutes (Figure 3.6 C). Endocytosis appears to slightly
reduce the CV of cytoplasmic BR to less than the CV BR in the PV space at 60
minutes (Figure 3.6 G). BR starts to decrease as Cv-2 increases since Cv-2 has
a stronger affinity for BMP. With the base parameter set, Cv-2 appears to be
acting negatively to decrease the overall amount of BR and BMP in the single cell
system. The addition of Cv-2 also increases the CV of BMP and BR in the PV
space, but endocytosed BR is protected from the inhibition. Thus endocytosis
may help create a stronger response to BMP signaling by protecting BR from
inhibition by Cv-2.
Although the means of the number of molecules for pMad, pMad2, pMMe
and pM3 are relatively small (less than 100), their CV’s are not large (Figure 3.6
G-L). While the propensity analysis predicted that the phosphorylation of Mad
was a major rate limiting step, there is only a very small increase in the CV of
BR compared to pMad (Figure 3.6 G). This may be due to the large amount of
Mad and Medea molecules attenuating the stochastic fluctuations. Even though
there are more BR molecules in the PV space than the cytoplasm, the amount
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and CV of pMad follows the trajectory of BRc. The degradation rate of pMad
is very slow, so the accumulation of pMad over time may help to attenuate the
fluctuations and inhibition of BR in the PV space. The active transcription factor,
pM3, is formed primarily through pMad combining with Medea and then another
pMad molecule combining with pMMec (Figure 3.5). This is not surprising as
the amount of Medea is high throughout the simulation, but there are very few
pMad molecules. It takes about 30 minutes before the first transcription factor is
formed, and almost as fast as that happens it binds to the promoter site (Figure
3.6 D). The noise in the transcription factor formation is one of the noisiest steps
in the model (Figure 3.6 H and J). However the noise does decrease after each
pMad species is formed. The nuclear accumulation of pMad decreases the noise
of the transcription factor as the CV of pM3 is higher in the cytoplasm than the
nucleus (Figure 3.6 J). The noise in the transcription factor, pM3, binding to the
promoter site increases steadily after transcription is initiated around 30 minutes
(Figure 3.6 K). This slow response is somewhat surprising and may be due to the
slow phosphorylation rate. Initially the level of RNA starts at 0 and starts to
slowly increase due to a low basal level of transcription. Then, around 40 minutes
the levels of RNA start to dramatically increase, and do not reach a steady state
by 60 minutes (Figure 3.6 E). The noise in RNA levels in the nucleus or cytoplasm
is fairly constant during the entire simulation (Figure 3.6 L). While there is noise
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in the RNA levels, there is much less noise in Cv-2 due to the high production rate
(Figure 3.6 L). When Cv-2 starts to inhibit the overall levels of signaling, there
is an increase in the CV of Cv-2. Thus, using best estimates from the literature
for the intracellular kinetics, our model suggests there is noise in the downstream
signaling network with the noisiest step being transcription factor formation.
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Figure 3.5: One Stochastic Realization of BMP Signaling with Slow Endocytosis-
One realization of the system with the slow endocytosis/exocytosis ratesken =
3.3 × 10−2µm/min and kex = 3 × 10−3µm/min. The blue line represents the
number of molecules for each respective species, except for DNA where 1 represents
the DNA promoter site is free and 0 represents the transcription factor pM3 is
bound to the DNA.
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Figure 3.6: Mean Number of Molecules and the Coefficient of Variation for the
System with Slow Endocytosis-The temporal evolution of the number of molecules
of different species in the system with the slow endocytosis/exocytosis rates ken =
3.3 × 10−2µm/min and kex = 3 × 10−3µm/min. A-F) The blue line represents
the number of molecules for each respective species, except for DNA where 1
represents the DNA promoter site is free and 0 represents the transcription factor
pM3 is bound to the DNA. The green line represents the CV for each respective
species. G-L) The CV between different species is compared. The results are
generated from 50 realizations of the stochastic system.
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Signal Responses to Different Levels of BMP
Since different positions along the D/V axis are exposed to different levels of
BMP in the BMP morphogen gradient, we studied the stochastic dynamics of the
system at different production rates of BMP. Figure 3.7 shows the mean and CV
of number of molecules of key species for different production rates of BMP. When
C starts to be produced it transiently increases the noise level in the downstream
network. However, as the system equilibrates to the negative feedback of Cv-2,
the levels of noise decreases. The time at which this occurs is sooner with stronger
signaling. Thus by 60 minutes areas with higher signaling have less noise, whereas
areas with lower signaling have higher levels of noise in mRNA and Cv-2. The
simulations with larger levels of Cv-2 have higher levels of noise in free BMP and
bound receptor in the PV space (Figure 3.7 G-I). However the endocytosed bound
receptor has very low noise and endocytosis may help to buffer out the noise in the
PV space. Interestingly, the amount of buffering from endocytosis is similar for
all BMP production rates. Thus depending upon the position along the DV axis,
there are different levels of signaling leading to possibly higher levels of noise in
free BMP in high signaling domains but lower levels of noise in the overall amount
of signaling as measured by mRNA levels.
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Figure 3.7: The Mean and CV of Selected Species at Different Production Rates
of BMP- Here I use the slow endocytosis/exocytosis rates ken=3.3x10-2um/min
and kex=3x10-3um/min. The red, dark blue, black, green, and light blue lines
represents the number of molecules for each respective species, except for DNA
where 1 represents the DNA promoter site is free and 0 represents the transcription
factor pM3 is bound to the DNA. The red, dark blue, black, green, and light blue
represent B production rates of 2, 4, 5, 6, and 10 nM/min respectively. The results
are generated from 50 realizations of the stochastic system.
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The Role of Slow Endocytosis/Exocytosis in Signaling
Since the endocytosis rates measured for TGF-β signaling [129] are much lower
than rates measured for other signaling pathways such as the Epidermal Growth
Factor pathway [136], we studied how the system would respond with faster en-
docytosis and receptor recycling rates. At a low level of BMP the levels of the
stochastic fluctuations in RNA and proteins, measured by CV, stay constant over
time in the system with slow endocytosis/exocytosis. However, they decrease in
the system with fast endocytosis/exocytosis. Figures 3.6 and 3.8 show the mean
and CV of the number of total molecules of key species in different domains of
the stochastic system with different endocytosis and exocytosis rates. In both
figures the temporal evolution of pMad in the cytoplasm follows the temporal
evolution of BMP-bound receptors in the cytoplasm, which implies that endocy-
tosis is important for signaling. In addition, although the ratio of the endocytosis
and exocytosis rates in two settings are the same, pMad increases faster in the
system with faster endocytosis/exocytosis promoting the feedback loop (Figure
3.8). As a result the CV of RNA begins to decrease after 30 minutes, which
is when the feedback loop takes effect (Figure 3.8 E), while in the system with
slow endocytosis/exocytosis rates the CV of RNA stays constant (Figure 3.6 E).
Thus the rate of endocytosis may have a large effect on regulating the strength of
145
signaling.
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Figure 3.8: Mean and CV of Species in the 3D Stochastic Model with Fast
Endocytosis- The molecular temporal evolution of different species in the sys-
tem with the fast endocytosis/exocytosis rates ken = 3.3 × 10−1µm/min and
kex = 3 × 10−2µm/min. A-F) The blue line represents the number of molecules
for each respective species, except for DNA where 1 represents the DNA promoter
site is free and 0 represents the transcription factor pM3 is bound to the DNA.
The green line represents the CV for each respective species. G-J) Comparison
of the CV between species. The results are generated from 10 realizations of the
stochastic system.
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Influence of Phosphorylation Rate on Evolution of 3D Stochastic Model
Since the propensity analysis showed that the phosphorylation rate may be a rate
limiting step in the model, we studied how the model changes with increasing the
phosphorylation ration by 10 and 100 times (Figures 3.9 and 3.10). An increase
in the phosphorylation rate lead to an earlier and lower peak of bound receptor
in the PV space (Figures 3.9 and 3.10 B) since Cv-2 was produced at both higher
levels and an earlier time point. The level of cytoplasmic BR also decreased as
the phosphorylation rate increased (Figures 3.9 and 3.10 C). The level of noise of
free BMP and bound receptor in the cytoplasm increased, while noise of bound
receptor in the cytoplasm was unchanged (Figures 3.9 and 3.10 G). Despite hav-
ing lower levels of bound receptor the time at which the promoter site turned on
significantly decreased (Figures 3.9 and 3.10 D). There was also a large decrease
in the noise of transcription factors in the cytoplasm and nucleus (Figures 3.9
and 3.10 H and I). The nuclear accumulation of the transcription factor no longer
decreased the noise in nuclear transcription factor compared to the cytoplasmic
transcription factor (Figures 3.9 and 3.10 H). The level of mRNA and Cv-2 pro-
duced also significantly increased as the phosphorylation rate decreased (Figures
3.9 and 3.10 E and F). Thus the levels of molecules in the system and the overall
noise were greatly affected by phosphorylation rate.
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Figure 3.9: Mean and CV of Species in the 3D Stochastic Model with 10 Times
Base Phosphorylation Rate- The molecular temporal evolution of different species
in the system with the base parameters and no Cv-2 in the model. A-F) The
blue line represents the number of molecules for each respective species, except
for DNA where 1 represents the DNA promoter site is free and 0 represents the
transcription factor pM3 is bound to the DNA. The green line represents the CV
for each respective species. G-J) Comparison of the CV for different species in the
model. The results are generated from 19 realizations of the stochastic system.
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Figure 3.10: Mean and CV of Species in the 3D Stochastic Model with 100 Times
Base Phosphorylation Rate- The molecular temporal evolution of different species
in the system with the base parameters and no Cv-2 in the model. A-F) The
blue line represents the number of molecules for each respective species, except
for DNA where 1 represents the DNA promoter site is free and 0 represents the
transcription factor pM3 is bound to the DNA. The green line represents the CV
for each respective species. G-J) Comparison of the CV for different species in the
model. The results are generated from 19 realizations of the stochastic system.
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Cv-2 Knockout in 3D Stochastic Model
To compare our model with the experimental results for the Cv-2 knock out, we
studied how the model was effected when Cv-2 was not allowed to be produced
from mRNA (Figure 3.11). There was a large increase in the level of both free
BMP and BR in the PV space and cytoplasm (Figure 3.11 A and B). However the
time at which the promoter site first become occupied was similar (Figure 3.11 D).
In agreement with experimental results from chapter 2, there was a slight decrease
in the noise of the transcription factor in the nucleus, but there was no change in
the noise in RNA levels (Figure 3.11 I). Thus our model has similar behavior to
the experimental results where an increase in signaling and a decrease in noise of
the transcription factor is seen when Cv-2 is knocked out of the model.
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Figure 3.11: Mean and CV of Species in the 3D Stochastic Model with no Cv-2-
The molecular temporal evolution of different species in the system with the base
parameters and no Cv-2 in the model. A-F) The blue line represents the number
of molecules for each respective species, except for DNA where 1 represents the
DNA promoter site is free and 0 represents the transcription factor pM3 is bound
to the DNA. The green line represents the CV for each respective species. G-J)
Comparison of the CV for different species in the model. The results are generated
from 50 realizations of the stochastic system.
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3.3.3 Noise Propagation in a Simplified Model of BMP
Signaling
A simplified model of the BMP signaling network was made to better understand
how noise propagates through the signaling network and how a Cv-2 like molecule
influences the noise propagation (Figure 3.12). The simplified network is a linear
chain of reactions with a nonlinear feedback step using the dynamics of Cv-2. The
model consists of B which is produced at a constant rate. B can go to BR directly
or through a co-receptor Cv-2. BR catalyzes the production of pMad. pMad
then catalyzes the production of mRNA. The mRNA catalyzes the production of
C. C can bind with B to form BC, which can then pass B to BR. We assume
the receptors are in excess in this model. We will let the reactions of B, BR, C,
and BC occur in Volume V1, reactions for mRNA occur in volume V2, and pMad
occur in volume V3. We will analyze this model stochastically to see how noise
propagates through this signaling network.
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O       B        BR        pMad        mRNA        C   
B        BR 
BC   
A) 
B) 
Figure 3.12: Diagram of Simplified Model for BMP Signaling- A) A simplified
model of BMP signaling with C either enhancing or inhibiting the rate of B
going to BR. B) C interacts reversibly with both B and BR as proposed for the
mechanism of Cv-2.
We first analyzed the model with no feedback. The model reaches a steady
state very rapidly. Most of the free B molecules react to become BR. BR catalyzes
the formation of pMad, which then catalyzes the formation of mRNA. mRNA
creates C, but C does not react with B or BR in this model. The noisiest molecule
is B, which has a CV of 0.79. All other species have a very low CV, with the CV
of mRNA being slightly higher than B, BR, or C. While this simple linear model
is not that interesting, it provides a foundation for comparing the results when
feedback is added into the model.
The interaction of BC to BR is not well understood, so we performed a pa-
rameter scan by changing the Kd and the rate of the individual reactions for the
same Kd for BR to BC. As the Kd increases, the average number of molecules for
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different species in the system gets closer to the case where there is no inhibition.
For very large Kds the CV of B is significantly larger than when there is no inhi-
bition, but for all other species the CV is similar to the case of no inhibition. For
smaller Kd values there is a larger amount of free B and a smaller B CV. Whereas
the opposite is true for all other species. We tracked if the BC species was formed
from B or BR. Except for when the Kd was 2, 20, or 200 and k−7 was 0.001, most
of BC was formed from BR. Within the same Kd value, the on and off rates also
make a difference on the levels of molecules. However, there are different trends in
how the means change depending upon the magnitude of the Kd. Thus, in order
to know how the system evolves it is important to know not only the Kd value
but also the on and off rates.
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Parameter Change Kd B BR C BCb BCr BC pMad mRNA
no feedback N/A 1.5 101.67 210.42 - - - 315.32 28.9
k7 = 0.002, k−7 = 0.1 0.02 4.04 32.21 2.88 8.13 57.55 65.68 100.2 8.79
k7 = 0.2, k−7 = 10 0.02 4.6 31.98 0.14 0.12 66.78 66.91 98.82 8.73
k7 = 0.02, k−7 = 0.1 0.2 3.92 32.57 3.06 8.22 58.43 66.65 100.21 9.09
k7 = 0.2, k−7 = 1 0.2 4.31 31.39 0.59 1.07 64.16 65.23 97.37 8.79
k7 = 0.002, k−7 = 0.001 2 1.33 47.7 43.03 39.84 12.73 52.57 145.03 13.21
k7 = 0.02, k−7 = 0.01 2 2.6 38.66 15.78 24.86 35.89 60.75 118.96 10.66
k7 = 0.2, k−7 = 0.1 2 3.67 34.26 4.93 6.64 57.5 64.13 105.49 9.57
k7 = 2, k−7 = 1 2 3.97 32.42 2.87 0.82 64.79 65.51 100.48 9.22
k7 = 20, k−7 = 10 2 3.88 32.53 2.79 0.06 63.3 63.36 101.11 9.03
k7 = 0.02, k−7 = 0.001 20 1.38 48.38 47.5 37.3 13.63 50.94 149.62 13.62
k7 = 0.2, k−7 = 0.01 20 2.1 41.93 26.67 18.49 38.99 57.47 129.83 11.79
k7 = 2, k−7 = 0.1 20 2.2 39.96 21.24 3.35 56.12 59.47 122.83 10.92
k7 = 0.2, k−7 = 0.001 200 0.7 60.87 84.66 22.7 17.33 40.03 186.78 16.86
k7 = 20, k−7 = 0.1 200 0.75 61.23 85.11 0.45 39.64 40.09 189.93 17.11
k7 = 40, k−7 = 0.1 400 0.5 70.5 113.92 0.21 29.71 29.92 217.35 19.48
k7 = 100, k−7 = 0.1 1000 0.41 82.97 150.25 0.06 19.05 19.11 256.94 23.65
k7 = 200, k−7 = 0.1 2000 0.3 90.77 171.84 0.03 11.83 11.86 280.45 25.31
k7 = 40, k−7 = 0.001 40000 0.2 101.28 203.93 0.12 0.81 0.93 311.73 28.18
k7 = 100, k−7 = 0.001 100000 0.2 102.52 205.47 0.05 0.32 0.37 316.67 29.24
k7 = 200, k−7 = 0.001 200000 0.2 100.64 204.22 0.02 0.15 0.17 309.71 27.79
Table 3.11: Mean Number of Molecules for Species in the Simplified Model for a Parameter Scan of BR to BC-
A parameter scan for the interaction between BR and BC was performed. The Kd is for BR to BC. k7 is the
rate of BR− > BR + C and k−7 is the rate BR + C− > BR. The simulation was run for 60 minutes and the
results of the last 10 seconds were averaged. Each parameter set is from 50 simulations.
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Parameter Change Kd B BR C BCr BCb BC pMad mRNA
no feedback N/A 0.79 0.09 0.1 N/A N/A N/A 0.11 0.21
k7 = 0.002, k−7 = 0.1 0.02 0.51 0.2 0.58 0.14 0.42 0.13 0.2 0.38
k7 = 0.2, k−7 = 10 0.02 0.44 0.2 2.57 0.13 3.28 0.13 0.2 0.39
k7 = 0.02, k−7 = 0.1 0.02 0.51 0.18 0.59 0.13 0.39 0.13 0.19 0.39
k7 = 0.2, k−7 = 1 0.2 0.5 0.2 1.34 0.13 1.02 0.13 0.19 0.39
k7 = 0.002, k−7 = 0.001 2 0.85 0.15 0.14 0.3 0.16 0.15 0.15 0.31
k7 = 0.02, k−7 = 0.01 2 0.58 0.16 0.23 0.17 0.21 0.13 0.17 0.35
k7 = 0.2, k−7 = 0.1 2 0.5 0.19 0.45 0.13 0.44 0.13 0.18 0.37
k7 = 2, k−7 = 1 2 0.5 0.19 0.59 0.13 1.16 0.13 0.19 0.36
k7 = 20, k−7 = 10 2 0.52 0.21 0.62 0.14 N/A 0.14 0.21 0.4
k7 = 0.02, k−7 = 0.001 20 0.82 0.13 0.13 0.16 0.25 0.14 0.15 0.31
k7 = 0.2, k−7 = 0.01 20 0.7 0.15 0.2 0.16 0.25 0.13 0.15 0.41
k7 = 2, k−7 = 0.1 20 0.7 0.16 0.23 0.14 0.56 0.14 0.15 .33
k7 = 0.2, k−7 = 0.001 200 1.17 0.12 0.11 0.24 0.22 0.17 0.13 0.28
k7 = 20, k−7 = 0.1 200 1.19 0.12 0.11 0.16 1.46 0.15 0.11 0.27
k7 = 40, k−7 = 0.1 400 1.51 0.11 0.1 0.19 2.2 0.19 0.11 0.25
k7 = 100, k−7 = 0.1 1000 1.57 0.1 0.1 0.25 4.54 0.25 0.11 0.22
k7 = 200, k−7 = 0.1 2000 1.81 0.094 0.093 N/A 0.29 0.29 0.1 0.22
k7 = 40, k−7 = 0.001 40000 0.81 0.1 0.1 3.07 1.14 1.06 0.12 0.23
k7 = 100, k−7 = 0.001 200000 2.29 0.09 0.09 N/A 1.81 1.66 0.1 0.21
k7 = 200, k−7 = 0.001 200000 2.41 0.09 0.08 N/A 2.77 2.62 0.1 0.21
Table 3.12: CV for Molecules for Species in the Simplified Model for a Parameter Scan of BR to BC- A
parameter scan for the interaction between BR and BC was performed. The Kd is for BR to BC. k7 is the rate
of BR− > BR+C and k−7 is the rate BR+C− > BR. The simulation was run for 60 minutes and the results
of the last 10 seconds were averaged. Each parameter set is from 50 simulations.
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We also performed a parameter scan where each reaction rate in the simplified
model was increased and decreased by 10 fold. When the rate of B to BR was
decreased, all downstream species also decreased. When the rate of BR to pMad
was decreased all species in downstream steps decreased, and BR increased due to
less inhibition by C. Similar results were found for decreasing the rate at succes-
sively lower points in the signaling network. The opposite occurred for increasing
BR. When the rate of BC to B+C was decreased there was slightly less signaling
in the network. Increasing the rate of BC to B+C had a very small effect on the
amount of signaling, but a large effect on increasing the levels of free B. Changing
the rates from B to BR and B to BC had the smallest effects on the network.
Interestingly, the level of free B was a very poor indicator of the total level of sig-
naling in the network. Thus both the levels of free B and amount of signaling as
measured by BR or pMad are very sensitive to the network parameters and there
is a very poor correlation between levels of free B and the amount of signaling.
There were no clear trends in how CV changed when the reaction rates in
the simplified model was increased or decreased by 10 fold. Decreasing the rate
of B to BR had little effect on the CV of the species except for free B and BC
formed from B which decreased by approximately half. Whereas, increasing the
rate of B to BC doubled the noise in B and tripled the noise in BC formed from
B interacting with C. When the rates downstream of BR were decreased, the CV
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of BR decreased and when the rates increased the CV increased. However for
the CV of B increased for both a decrease or an increase in rates downstream of
BR. The CV of pMad was unchanged by increasing the rate of pMad production,
but was increased when the production rates of mRNA or C increased. In all
three cases for pMad the level of BR and BC were similar. Thus the noise level
for different species varied greatly with the overall parameter rates and it is not
easy to predict how the CV will change for different species upon changing kinetic
rates.
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Parameter Change B BR C BCb BCr BC pMad mRNA
no feedback 1.5 101.67 210.42 - - - 315.32 28.9
Base Case 3.97 32.42 2.87 0.82 64.79 65.51 100.48 9.22
B->BR 0.1X 18.14 28.62 2.86 3.39 52.34 55.73 87.98 7.85
B->BR 10X 0.43 34.26 3 0.12 66.55 66.67 105.56 9.55
BR->pMad 0.1X 2.09 81.33 0.49 0.06 16.4 16.46 24.78 2.3
BR->pMad 10X 3.11 5.95 23.49 4.69 88.3 92.98 177.13 15.69
pMad->mRNA 0.1X 2.15 81.74 0.36 0.05 16.34 16.34 251.35 2.26
pMad->mRNA 10X 3.05 5.9 23.95 4.74 87.1 91.84 17.54 16.14
mRNA->C 0.1X 2.26 84.12 0.27 0.05 16.34 16.41 257.67 23.72
mRNA->C 10X 2.94 5.9 23.89 4.79 88.39 93.18 17.58 1.61
B+C->BC 0.1X 4.34 33.89 2.7 0.09 63.19 63.28 103.4 9.49
B+C->BC 10X 0.43 34.4 2.57 7.31 60.30 67.61 105.21 9.59
BC->B+C 0.1X 1.33 34.13 2.57 0.23 66.33 66.56 106.02 9.91
BC->B+C 10X 22.42 27.12 4.71 5.17 46.23 51.4 83.18 7.61
Table 3.13: Parameter Scan for the Mean Number of Molecules for Species in the Simplified Model- A parameter
scan for the production rates of the molecules in simplified model was performed. The simulation was run for
60 minutes and the results of the last 10 seconds were averaged. Each parameter set is from 50 simulations.
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Parameter Change B BR C BCb BCr BC pMad mRNA
no feedback 0.79 0.09 0.1 - - - 0.11 0.21
Base Case 0.5 0.19 0.59 1.16 0.13 0.13 0.19 0.36
B->BR 0.1X 0.24 0.19 0.61 0.55 0.15 0.14 0.18 0.39
B->BR 10X 1.55 0.19 0.58 3.07 0.12 0.12 0.19 0.36
BR->pMad 0.1X 0.69 0.11 1.28 4.56 0.27 0.27 0.23 0.72
BR->pMad 10X 0.59 0.43 0.22 0.1 0.48 0.1 0.2 0.32
pMad->mRNA 0.1X 0.67 0.11 1.57 4.83 0.28 0.28 0.12 0.67
pMad->mRNA 10X 0.57 0.43 0.25 0.47 0.1 0.1 0.29 0.39
mRNA->C 0.1X 0.64 0.13 1.91 N/A 0.24 0.24 0.15 0.24
mRNA->C 10X 0.57 0.44 0.3 0.48 0.12 0.12 0.33 0.81
B+C->BC 0.1X 0.49 0.19 0.64 3.69 0.13 0.13 0.18 0.37
B+C->BC 10X 1.52 0.18 0.65 0.37 0.14 0.13 0.19 0.37
BC->B+C 0.1X 0.86 0.18 0.62 2.1 0.12 0.12 0.18 0.36
BC->B+C 10X 0.19 0.24 0.51 1.33 0.18 0.13 0.22 0.4
Table 3.14: Parameter Scan for the CV of Molecules for Species in the Simplified Model- A parameter scan
for the production rates of the molecules in simplified model was performed. The simulation was run for 60
minutes and the results of the last 10 seconds were averaged. Each parameter set is from 50 simulations.
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Discussion Analysis of signaling output in cell culture suggests that the num-
bers of BMP molecules in vivo during dorsal patterning may be in the range of 10-
100 molecules / nucleus [50] indicating stochasticity may be important. We have
created a stochastic model that integrates BMP signaling on the plasma membrane
with the intracellular dynamics of transcription factor formation, transcription,
translation, and a positive feedback mechanism where the product of translation
feeds back to influence the dynamics on the plasma membrane. This model draws
upon four different deterministic models: a positive feedback model in which BMP
signaling to induce a contraction and intensification of BMP signaling on the dor-
sal surface on the plasma membrane [52], a model using exocytosis and endocytosis
of membrane receptors [120], a nuclear shuttle transport system model that leads
to nuclear accumulation of pMad [121], and a new model of transcription and
translation. The levels of BR, B and C in our single cell model are consistent
with the previous spatial deterministic models in [52]. While there are models
that have integrated the full TGF-β signaling network together [122, 123, 120],
they have not included feedback that regulates the signaling pathway, nor have
they been studied in detail with stochastic models. Our 3-Dimensional spatial
stochastic model allows us to study in detail mechanisms of noise propagation
throughout the BMP signaling network.
Frequency analysis of reactions and diffusion in the system show that it has
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multi-scale organization. The phosphorylation of Mad to pMad and transport
across the nucleus are possible rate limiting steps, and diffusion of BMP, MAD,
and Medea is relatively fast. As a result, all the species except DNA and RNA’s
are well mixed in the simulation results. Due to the slow phosphorylation of Mad,
the fluctuations of pMadc are much larger than the fluctuations of their upstream
product BRc. The slow phosphorylation step leads to the transcription factor
formation being the noisiest step in the overall model. While w3 used the phos-
phorylation estimated from fitting a model to experimental data in [121], it was
not directly measured. When the phosphorylation rate was increased, there was a
significant decrease in the noise in transcription factor formation and a significant
reduction in the time when transcription was initiated. Since this is a rate limit-
ing step in our model it may be worth more closely studying the phosphorylation
rate experimentally. Similar to phosphorylation, slow transport across the nuclear
membrane could lead to large fluctuations of transcription factors. However, nu-
clear accumulation of the transcription factors may reduce the fluctuations and
cancel the amplifying effect of slow transport. Overall the nuclear accumulation
reduced fluctuations in active transcription factor in the cytoplasm. Thus an-
other role for the nuclear accumulation may be noise filtering. While there are
rate limiting steps such as phosphorylation and BMP receptor binding, there are
downstream steps that function to filter out some of the noise.
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Positive feedback provided by a co-receptor that sequesters the BMP ligand
and helps to transfer it to the receptor has been suggested as a key factor in allow-
ing for a bistable signaling system, where for the same amount of free BMP there
can be two different steady states for gene transcription. We used a very rough
approximation of the signaling dynamics in the PV space by varying the levels of
BMP produced. In the single cell system, we found very different dynamics for a
surface binding molecule than the Umulis model [52]. In our model, the surface
binding protein only served to sequester and inhibit the total amount of BMP
signaling. When Cv-2 was removed from the model, there were higher levels of
signaling and less noise in the nuclear transcription factor. However, these results
are consistent with the experimental observations highlighted in chapter 2 as well
as several other in vivo experimental systems where Cv-2 serves as an inhibitor
[96, 97, 98, 99, 89, 92]. In cell culture, Cv-2 was also shown to more often be
an inhibitor than an activator of BMP-2, which is the vertebrate homologue of
Dpp [57]. In our system when Cv-2 feeds back to inhibit signaling, it transiently
increases the total level of noise in the system. This result is consistent with
the experimental work in Chapter 2 where the Cv-2 null embryos had a trend
of slightly higher noise in the width of nuclear pMad staining. Thus our model
is consistent with experimental results that Cv-2 can enhance the overall noise
in the system through inhibiting signaling. It would be interesting to extend my
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model to study how noise propagates when Cv-2 is an activator of BMP signaling.
In our single cell system there is no competition for signaling molecules, which
makes it hard to show the two steady states for one level of BMP, but differences
in the timing of gene activation can be observed. In order to study if the model
is capable of producing multiple steady states, it would need to be extended to
multiple cells. Karim et al. studied a stochastic model of BMP signaling with Cv-
2 over a field of cells and found Cv-2 can help sharpen the boundaries [71]. In their
model they did not include the downstream network components or endocytosis,
which our model suggests may be important in creating a sustained BMP signaling
and filtering noise. In addition, while they indicated that there are parameter
regimes where Cv-2 increases noise, they did not study it in detail. A careful study
of how the system responds under negative feedback, which is observed during
dorsal surface patterning, may be warranted. However to extend our system to
multiple cells, some of the downstream steps may need to be simplified as it may
be too computationally expensive to simulate all the details for multiple cells.
While our model hints at being able to create different levels of signaling based
on different concentrations of BMP, more work is needed to see if it can produce
boundaries between high and low signaling levels.
Our model implemented endocytosis in a more detailed manner than previous
models, allowing for signaling in the cytoplasm and recycling of receptors. When
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endocytosis is high, there is cytoplasmic accumulation of receptors and BMP
bound receptors and most of the active signal came from the endocytosed bound
receptors. Since BR cannot dissociate in the cytoplasm and B will be removed
from the system once cytoplasmic BR, BCR and BC get exocytosed; exocytosis
and endocytosis can either enhance signaling through increasing BR or inhibit
signaling by removing B. In our model the enhanced endocytosis rates led to
much stronger signaling. This is consistent with previous mathematical models
that have suggested that endocytosis is necessary for sustained response to TGF-
beta signaling [123, 120]. The accumulation of BMP receptors cytoplasmically
also reduces noise in BMP signaling on the plasma membrane. This reduction
of noise is very important for the precision of signaling in the system, since the
fluctuations in the downstream phosphorylation of pMad are large. Therefore,
endocytosis and exocytosis may be a key mechanism in modulating the levels of
BMP signaling, helping allow for different thresholds of gene expression to be
reached, and attenuating fluctuations in the signal transduction pathway.
The simplified model allowed for a more expanded parameter scan to study
how Cv-2 affects noise propagation in a signaling network. In the simplified model,
Cv-2 was an inhibitor of signaling. The levels of free BMP were greatly affected
by changing different parameters. However there were not clear trends for how the
level of free BMP changed. Thus, free levels of BMP may not be the best estimate
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for the amount of signaling that is occurring. In areas with higher signaling and
higher levels of Cv-2, there may be less free BMP. Instead it may be better to
directly study the levels of bound receptor or pMad. The model was sensitive
to the Kd for going between bound receptor and BMP bound to Cv-2 and the
individual reaction rates. Thus it is important to know the time scale of the
reaction between Cv-2 bound with BMP and the BMP receptor. The simplified
model indicates it may be important to more closely study the reaction rates
during D/V patterning in order to better understand how Cv-2 modulates the
signaling network.
In summary, the BMP signaling system is very robust and appears to have
evolved many different methods to reduce noise that arises for either low numbers
of molecules or slow steps in the signaling process. Due to the different time
scales of reactions and transport, the CV is larger at slow reaction steps and
small at fast ones. In the PV space, the large number of receptors can help
reduce the noise from only a few free BMP molecules. For the exocytosis and
endocytosis mechanism, the accumulation of the cytoplasmic BR can cancel the
large fluctuations in pMad caused by slow phosphorylation of Mad. Due to the
one-directional transport mechanisms, the nuclear accumulation of transcription
factors can reduce the fluctuations caused by slow transport across the nuclear
membrane. Thus while there are noisy steps due to low production rates of BMP
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and slow phosphorylation, there are multiple steps in the signaling pathway to
help filter the noise.
Chapter 4
Conclusion and Discussion
In this thesis I have studied robustness and feedback control of BMP signaling
during dorsal surface patterning in Drosophila melanogaster. BMP signaling is an
important signaling pathway that is used throughout development for embryonic
axis specification, organogenesis, and apoptosis. In order to better understand reg-
ulation of the BMP signaling pathway I have studied how it influences patterning
of the embryonic dorsal surface through three projects. Using molecular biology
and genetics I have studied the role of Crossveinless-2 and Nejire in the feedback
control of BMP signaling. Using the experimental results for Crossveinless-2 I
have collaborated with Dr. Likun Zheng to develop a 3-D stochastic model of
BMP signaling for a single cellular compartment during dorsal surface patterning.
A stochastic model of BMP signaling is necessary since the free levels of BMP
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have been proposed to be less than 100 molecules per nucleus, which would indi-
cate that stochasticity or noise may be present during dorsal surface patterning.
The 3-D stochastic model has allowed us to study how noise propagates through
the BMP signaling network during early embryogenesis. These projects help us
to better understand the feedback control of BMP signaling.
I have identified a new allele of nej that contains a stop codon in the 12th
exon of the gene. The stop codon truncates part of the highly enriched glutamine
domain that is important for transcriptional activation. Based on comparisons to
other nej alleles I believe this is a dominant negative allele. It most likely functions
to bind other transcription factors, but prevents or greatly decreases the levels of
transcriptional activation. Maternal loss of this new novel allele leads to a loss
of robust patterning of BMP signaling on the dorsal surface. In the pre-cephalic
furrow embryo there was loss of BMP signaling in the central region along the
A/P axis. All embryos had some staining in the anterior region, but a few had
staining in the posterior region. Half of the embryos recovered to relatively normal
patterning, and the other half had a variable loss of BMP signaling in the central
and posterior regions. During gastrulation half of the embryos were fairly normal
and the other half had significant expansion of BMP signaling. Thus our data
suggests there may be zygotic rescue of patterning just before gastrulation and
we plan on following up on this in the future. We have not studied phenotype for
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zygotic loss of the allele, and I plan to do so in the future. The maternal phenotype
of the allele is highly variable indicating nej may be required for consistent and
robust patterning of the dorsal surface.
I have found cv-2 is a BMP response element that is a negative regulator of
BMP signaling during dorsal surface patterning. This result is different from the
role of Cv-2 during BMP signaling in the wing disc crossvein formation where it
serves as an activator of BMP signaling [57]. However results from the homologue
of Cv-2 in vertebrates indicate that the role Cv-2 plays may be highly context
dependent. The negative inhibition of BMP signaling lowers the overall peak
signaling of the gradient. In Cv-2 null embryos the intracellular signal of BMP
receptor activation, pMad, is wider by 20-30%. This change in patterning is
significant since it leads to a larger amnioserosa later in embryonic development.
While Cv-2 appears to contribute to sharpening of the BMP gradient during dorsal
surface patterning, this comes at a cost of a slight decrease in robustness. Thus
Cv-2 is in a negative feedback loop in the BMP signaling pathway and contributes
to helping with contraction of the BMP gradient during dorsal surface patterning.
An open question is how the BMP gradient during dorsal surface patterning
both contracts and intensifies around the dorsal midline. Mathematical model-
ing has suggested that a positive feedback loop could explain the simultaneous
contraction and intensification of BMP signaling, and Cv-2 was proposed to be a
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molecule that was in the positive feedback loop [52]. However my experimental
results do not support this hypothesis. While Cv-2 does contribute to the overall
contraction of the gradient, it is insufficient for completely explaining the contrac-
tion and intensification. Thus there are most likely one or more molecules that
are involved in a feedback loop to sharpen the BMP morphogen gradient. These
unknown molecules may act synergistically with Cv-2, thus it may be necessary to
knock out more than one protein in the early embryo to lose both the contraction
and intensification of BMP signaling.
Through working with the cv-2 1−/− allele, I have noticed that Cv-2 null flies
may be hyperactive compared to yw controls. It would be interesting to test
activity levels of the cv-2 1 flies to see if this increase in activity is statistically
significant. ModEncode Data from flybase shows that Cv-2 is expressed in the
central nervous system throughout development and in the adult fly. During
vertebrate development, Cv-2 is involved in neural crest cell migration [97]. Some
of the derivatives of neural crest cell migration are cranial and sensory neurons
and glia [137]. In addition BMP signaling is important for neural tube patterning
[138]. One study in vertebrates has proposed that the duration of BMP signal
is important for dorsal neuronal subtype identity [139]. Thus it is plausible that
Cv-2 is involved in regulating BMP activity for proper formation or activity of
the nervous system in Drosophila.
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The levels of free BMP have been proposed to be in a stochastic range. To
study how noise may affect the robustness of BMP signaling I have created a
3-D stochastic model of BMP signaling in collaboration with Dr.Likun Zheng.
This model has allowed us to study how noise propagates through the signaling
network. My experimental results indicated that Cv-2 may have increased the
noise of BMP signaling during dorsal surface patterning. The stochastic model
showed an increase of noise in the system when Cv-2 started to inhibit the BMP
signaling pathway in the PV space through competition for the BMP ligand,
which is in agreement with experimental results. Our stochastic model indicated
that endocytosis may be important for both creating a stronger response to BMP
receptor binding and reducing noise in BMP signaling. We also found that the
slow phosphorylation step created noise in transcription factor formation. The
phosphorylation rate we used was estimated from a mathematical model that was
fit to experimental data. Thus, it may be interesting to confirm this rate with
further experiments since it is a critical noise propagation step in our model. I
also found that nuclear accumulation of the transcription factor was a mechanism
that can decrease noise in transcription factor levels. My model suggests that
while there are steps that enhance noise in the BMP signaling pathway, there are
also multiple mechanisms that function to filter out the noise.
My stochastic model of BMP signaling only studied how the pathway evolves
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for one nucleus. It would be interesting to expand this model to study how stochas-
ticity impacts patterning of the dorsal surface. There is a previously published
stochastic model that looks at BMP signaling in field of cells, but does not study
in detail the downstream network [71]. Our model suggests that the downstream
network may be important in the propagation of noise. Thus it would be inter-
esting to create a hybrid of these two models to study stochasticity in morphogen
gradient formation. However, simulating the downstream network is computa-
tionally very expensive. Thus simplifications will be needed to extend the results
to a field of cells based on currently available computing power.
In conclusion I have studied the robustness and feedback control of BMP
signaling during early Drosophila development. I have used both mathematical
modeling and developmental biology techniques to understand how the BMP sig-
naling pathway is controlled by two different proteins, Nejire and Crossveinless-2.
Nejire appears to be required for robust and consistent patterning of the dor-
sal surface through BMP signaling. Crossveinless-2 is part of a negative feedback
loop that helps refine the BMP morphogen gradient on the dorsal surface. Intrigu-
ingly, Crossveinless-2 is not a robustness factor, but actually increases the noise
in BMP signaling. This finding has been confirmed with a 3-D stochastic model
of the BMP signaling pathway. The 3-D stochastic model also predicts that tran-
scription factor formation may also increase noise in the BMP signaling pathway.
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However, large number of receptors on the PV space, endocytosis, and nuclear
accumulation of transcription factors may be able to buffer noise produced by
low copy numbers of signaling molecules and slow steps in the signaling network.
While there is noise in BMP signaling, there are several mechanisms that help to
filter out that noise to create robust and consistent patterning of target tissues.
The work of this theis has allowed us to better understand the feedback control
and robustness of BMP signaling during dorsal surface patterning in Drosophila.
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Appendix A
Acronyms
Care has been taken in this thesis to minimize the use of jargon and acronyms,
but this cannot always be achieved. This appendix contains a table of acronyms
and their meaning.
A.1 Acronyms
Table A.1: Acronyms
Acronym Meaning
AM Average Method
A/P Anterior / Posterior
Continued on next page
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Table A.1 – continued from previous page
Acronym Meaning
B BMP in Mathematical Model
BC B bound to C in Mathematical Model
BCR B, C, and R in One Complex in Mathematical Model
BMP Bone Morphogenic Protein
BR Bound Receptor in Mathematical Model
C Cv-2 Like Molecule in Mathematical Model
CBP CREB Binding Protein
CV Coefficient of Variation
Cv-2 Crossveinless-2
Dpp Decapentaplegic
D/V Dorsal / Ventral
FI Fluorescence Intensity
Gbb Glass Bottom Boat
GFP Green Fluorescent Protein
His Histone
HSPG Heparan Sulfate Proteoglycan
Continued on next page
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Table A.1 – continued from previous page
Acronym Meaning
L(1)G0232 Lethal (1) G0232
Ltl Larval Translucida
Me Medea in Mathematical Model
MM Mixing Method
Mvent1 Maternal Ventralizing Factor-1
Nej Nejire
PCV Posterior Crossvein
PI Propidium Iodide
Pol Polymerase
PM Parallel Method
pM3 2 pMad Molecules and 1 Medea in a Complex in the Mathe-
matical Model
pMad Phosphorylated Mad
pMad2 Dimer of Two pMad Molecules in Mathematical Model
pMMe Dimer of pMad and Medea in Mathematical Model
Pnt Punt
Continued on next page
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Table A.1 – continued from previous page
Acronym Meaning
PV Perivitelline
R Receptor in Mathematical Model
RM Ratio Method
RNAp RNA Polymerase in Mathematical Model
RNAt RNA Elongation Complex in Mathematical Model
Sax Saxophone
SC Staining Control
Scw Screw
Sog Short Gastrulation
T Threshold
TGF-β Tkv Thickvein
Tld Tolloid
Tsg Twisted Gastrulation
V Volume
W White
Wt Wild Type
Continued on next page
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Acronym Meaning
*c Molecule in the Cytoplasm
*n Molecule in the Nucleus
*p Molecule in the PV Space
